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1 Abstract 
Prolonged and progressive podocyte injury leads to extensive proteinuria, scarred glomeruli 
and a decline in renal function. When left untreated, it develops chronic kidney disease (CKD) 
which often has poor prognosis. Disturbed gene regulation serves as both cause and/or 
consequence in the context of podocyte injury. Unravelling the gene regulatory circuits within 
podocytes is therefore a key step to introduce new curative and or palliative strategies for 
chronic kidney disease.  
Wt1 is a master transcription factor (TF) in podocytes and previous work has determined Wt1-
dependent gene regulatory networks in healthy adult podocytes. In this thesis, analysis of 
Wt1-directed gene regulation in a genetic mouse model of podocyte damage demonstrated 
that Wt1 executes a differential binding tactic on genomic elements during early phases of 
podocyte damage. This differential binding on the genome is reflected as differential pathway 
regulation in the course of podocyte injury. Key podocyte pathways such as collagen 
biosynthesis, collagen metabolism as well as Eph/Ephrin signaling are markedly compromised. 
Perturbation of these critical functions entails glomerular basement membrane thickening, 
collapse of foot processes and podocyte detachment from the basement membrane.  
Next, a genome-wide analysis of Tead1, another master transcription factor in podocytes, 
indicated the cooperative function of Wt1 and Tead1 on gene regulatory elements. Both Wt1 
and Tead1 are members of the podocyte-specific transcription factor network which regulates 
homeostasis and cell survival in podocytes. Interestingly, analysis of Tead1-dependent 
functions showed that Tead1 mainly regulates actin cytoskeleton dynamics and cell adhesion 
in podocytes. Tead1-dependent functions are chiefly directed via distal regulatory elements. 
Previously, enhancer-based gene regulation by Wt1 has been shown in podocytes. In line with 
this, examining the peak distribution of both Wt1 and Tead1 across the genome accentuates 
the high-impact role of enhancers in gene regulation in podocytes. Next, De novo motif 
enrichment analysis and motif conservation scores around the Tead1 peaks revealed 
enrichment not only for Tead1 motif but also for Wt1 and other partners of podocyte-specific 
TF network. Co-binding analysis of the Tead1 ChIPseq with our previous Wt1 ChIPseq dataset 
suggested that some of the Tead1-dependent functions are co-directed by Wt1 and vice versa.  
Finally, another set of complementary analysis was done in this thesis which unveils a different 
aspect of gene regulation in podocytes. Here, a highly parallel transcriptional profiling of more 
than 13,000 cells obtained from isolated mouse glomeruli was performed which identified the 
three main glomerular cell types i.e. podocytes, endothelial cells and mesangial cells. The 
comprehensive gene expression profile of all identified cell types is gathered in an interactive 
online atlas which can be queried based on gene names. In addition, novel markers for 
podocytes, endothelial cells and mesangial cells were introduced and validated by cross-
referencing with glomerular expression of such markers in Human Protein Atlas. Furthermore, 
cell heterogeneity assessment for podocytes and endothelial cells was done. Endothelial cells 
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showed four subpopulations relevant to different phases of their activation and proliferation. 
Podocytes, however, exhibited a more subtle trace for cellular heterogeneity. Thus, a new 
immunofluorescent staining approach was adopted to address the identified podocyte 
subpopulations. The results validated identification of subpopulations within podocytes based 
on the differential immunofluorescence signal for subpopulation markers observed in 
different podocytes within a glomerulus.  
Altogether, the novel findings throughout this thesis casts some light on tens of thousands of 
questions surrounding gene regulation in podocytes. 
  
3 
 
2 Zusammenfassung 
Anhaltende und progressive Podozytenschäden können zu einer ausgedehnten Proteinurie, 
vernarbten Glomeruli sowie einer Abnahme der Nierenfunktion führen. Unbehandelt kann 
dies zu einer chronische Nierenerkrankung (CKD) führen, welche sich oft durch eine schlechte 
Prognose auszeichnet. Eine gestörte Genregulation ist sowohl Ursache wie auch gleichzeitig 
Folge einer Podozytenschädigung. Die Entschlüsselung der Genregulationskreisläufe 
innerhalb der Podozyten ist daher ein wichtiger Schritt, um neue heilende oder zumindest 
lindernde Strategien für chronische Nierenerkrankungen zu entwickeln.  
Wt1 ist ein Master-Transkriptionsfaktor (TF) in Podozyten und in früheren Arbeiten konnten 
bereits Wt1-abhängige genregulatorische Netzwerke in gesunden adulten Podozyten 
nachgewiesen werden. In dieser Arbeit konnte durch die Analyse der Wt1-gesteuerten 
Genregulation in einem genetischen Mausmodell der Podozytenschädigung gezeigt werden, 
dass WT1 eine unterschiedliche Bindungstaktik an genomischen Elementen in frühen Phasen 
der Podozytenschäden aufweist. Diese differenzielle Bindung am Genom spiegelt sich als 
differentielle Regulierung des Signalweges im Laufe der Podozytenschädigung wider. Wichtige 
podozytäre Signalwege wie die Biosynthese von Kollagen, der Metabolismus von Kollagen 
sowie die Eph/Ephrin-Signalgebung sind merklich beeinträchtigt. Die Störung dieser kritischen 
Funktionen führt zu einer Verdickung der glomerulären Basalmembran, dem Kollaps der 
Fußfortsätze sowie dem Ablösen der Podozyten von der Basalmambran.   
Außerdem zeigte eine genomweite Analyse von Tead1, einem weiteren Master-
Transkriptionsfakter innerhalb von Podozyten, die zusammenwirkende Funktion zwischen 
Wt1 und Tead1 auf genregulatorischen Elementen. Sowohl Wt1 als auch Tead1 sind Mitglieder 
des podozytenspezifischen Transkriptionsfaktor-Netzwerkes, welches die Homöostase und 
das Zellüberleben in Podozyten reguliert. Interessanterweise zeigte die Analyse der Tead1-
abhängigen zellulären Funktionen, dass Tead1 hauptsächlich die Dynamik des 
Aktinzytoskelettes sowie die Zelladhäsion in Podozyten reguliert. Die Tead1-abhängigen 
Funktionen werden hauptsächlich über distale regulatorische Elemente gesteuert. Bisher 
konnte eine Enhancer-basierte Genregulation von Wt1 in Podzyten gezeigt werden. In diesem 
Zusammenhang unterstreicht die Untersuchung der  peak distribution von Wt1 und Tead1 im 
Genom die essentielle Rolle von Enhancern in der Genregulation in von Podozyten. Zusätzlich 
zeigte die De novo-motif enrichment analysis sowie der motif conservation scores um die 
Tead1-Peaks herum eine Anreicherung für nicht nur das Tead1-Motiv, sondern auch für Wt1 
und andere Partner des podozytspezifischen TF-Netzwerkes. Die Co-Bindungs-Analyse von 
Tead1 ChIPseq mit unserem vorherigen Wt1 ChIPseq-Datensatz deutete darauf hin, dass 
einige der Tead1-abhängigen Funktionen von Wt1 mitgesteuert werden und umgekehrt.  
Schließlich wurde in dieser Arbeit eine Reihe von komplementären Analysen durchgeführt, 
welche einen anderen Aspekt der Genregulation in Podozyten enthüllten. Dafür wurde eine 
hochparallele Transkriptionsprofilierung von mehr als 13.000 Zellen aus isolierten Maus-
Glomeruli durchgeführt, welche die drei wichtigsten glomerulären Zelltypen, d.h. Podozyten, 
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Endothelzellen und Mesangialzellen, identifizierte. Das umfangreiche Genexpressionsprofil 
von allen identifizierten Zelltypen wurde in einem interaktiven Online-Atlas 
zusammengestellt, in welchem nach einzelnen Gennamen gesucht werden kann. Zusätzlich 
wurden neue Marker für Podozyten, Endothelzellen und Mesangialzellen eingeführt und 
durch Querverweise mit der glomerulären Expression solcher Marker im humanen Protein-
Atlas validiert. Außerdem wurde die Zellheterogenität von Podozyten und Endothelzellen 
untersucht. Endothelzellen zeigten dabei vier Subpopulationen, welche für unterschiedliche 
Phasen ihrer Aktivierung und Proliferationen relevant sind. 
Demgegenüber wiesen Podozyten lediglich eine schwache Ausprägung für zelluläre 
Heterogenität auf. Aus diesem Grund wurde eine neue Immunofluoreszenzfärbung 
entwickelt, um die identifizierten Subpopulationen der Podozyten zu markieren. Die dadurch 
gewonnenen Ergebnisse validierten die Identifizierung von Subpopulationen innerhalb von 
Podozyten auf der Basis des unterschiedlichen Immunfluoreszenzsignals für 
Subpopulationsmarker, welche in verschiedenen Podozyten innerhalb eines Glomerulus 
beobachtet wurden.  
Zusammengefasst können die neuen Erkenntnisse, die in dieser Arbeit erzielt wurden, dazu 
beitragen, bei der Beantwortung einer Vielzahl von Fragestellungen rund um die 
Genregulation in Podozyten zu helfen.   
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3 Introduction 
3.1 Chronic kidney disease  
More than 10% of the world’s population are suffering from CKD. (Levin et al., 2017) With an 
estimated prevalence of 13.4% in 2016, CKD imposes a significant burden to healthcare 
systems worldwide. (Hill et al., 2016) Among the etiologies for CKD, 90% stems from 
glomerular diseases in which podocytes are damaged and lost. (Wiggins, 2007)  
Podocytes are terminally differentiated visceral epithelial cells which are the key components 
of establishing the selective permeability in the glomerulus. They consist of a cell body and 
cytoplasmic projections known as foot processes (FP). (Mundel and Kriz, 1995; Pavenstädt et 
al., 2003) Microtubules, intermediate filaments and actin cytoskeleton are the main structural 
and functional components of foot processes. (Andrews, 1981) In glomerulus, the 
interdigitated foot processes of adjacent podocytes are connected via special cell-cell contacts 
known as slit diaphragm (SD). (Fukasawa et al., 2009; Reiser et al., 2000) (Figure 3.1)  
 
Figure 3.1: Electron microscopy image of normal rat glomerular capillaries. 
 The capillary tuft is covered by the interdigitated foot processes of podocytes. CB: cell body, PP: 
primary processes, FP: foot processes; magnification ×∼6,000. Adopted from (Pavenstädt et al., 
2003)  
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The interdigitated foot processes, their underlying basement membrane known as the 
glomerular basement membrane (GBM) and the fenestrated endothelium establish the 
filtration barrier in the glomerulus. This exquisite structure and the negatively charged 
molecules within this barrier restrict the passage of proteins and guarantee a protein-free 
urine. When podocytes are damaged, the podocyte cytoskeleton undergoes massive 
dysregulation. The slit diaphragm becomes disintegrated and the foot processes collapse on 
their underlying GBM, a phenomenon known as effacement. (Figure 3.2) As a result, proteins 
leak into the primary urine filtrate. When this condition is persistent, excessive extracellular 
matrix deposition occurs leading to a thickened GBM; podocytes detach from the basement 
membrane and the sclerotic lesions develop. (Brinkkoetter et al., 2013; Haraldsson et al., 
2008; Perico et al., 2016; Yu et al., 2018)  
 
Figure 3.2: Transmission electron microscopy of human filtration barrier. 
Fenestrated endothelium is indicated by arrows. SD is indicated by arrowheads. Asterisks show actin 
filaments in FP. During effacement, abnormal FP architecture and flattened actin filaments are 
visible. Figure adopted and modified from (Mathieson, 2010) 
 
This chain of events is a histological phenomenon termed as Focal Segmental 
Glomerulosclerosis (FSGS) which is caused by primary (idiopathic) or secondary podocyte 
injury. FSGS refers to the partial scarring (segmental) of some but not all (focal) glomeruli in 
the kidney and it is a frequent pathological event in CKD. (Peev et al., 2017) (Figure 3.3) 
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Figure 3.3: Histology images of the kidney sections showing normal vs. sclerosed glomeruli.  
Periodic acidic Schiff (PAS) staining of kidneys from adult male FVB/N mouse (normal) and adult male 
Wt1 het del mouse (FSGS mouse model). Arrowheads show sclerotic lesions. Scale bar: 20 µm 
 
During the progression of FSGS, the remaining functional glomeruli are posed by increased 
blood shear stress which can accelerate podocyte damage. When left untreated, FSGS can 
eventually result in kidney failure. (Rosenberg and Kopp, 2017) There are numbers of 
medications frequently used to control the symptoms. According to the Kidney Disease 
International Guideline Organization, prolonged steroids should be considered as the first-line 
therapy for patients suffering from FSGS. Intolerant patients, however, should receive 
Calcineurin inhibitors (CNIs). (Beck et al., 2013) Despite all the beneficial effects of both 
therapy lines on the remission of symptoms, neither of the approaches are curative and safe. 
(Lafayette, 2019) The window for podocyte salvage to prevent disease progression in FSGS is 
very narrow and the missing novel therapeutic approaches depend on further longitudinal 
investigations into the mechanism of podocyte damage in its early stage.  
In recent years, the genetic factors contributing to the development of FSGS have caught 
increasing attention. Hereditary FSGS has been attributed to mutations in genes encoding for 
the important podocyte molecules. (Fogo, 2015; Wang et al., 2019) Table 3-1 enlists some but 
not all gene mutations resulting in hereditary FSGS. Although all these genes are crucial for 
the maintenance of podocyte homeostasis, some of them have a more central role in 
coordinating biological processes within the podocytes. Transcription factors are one of the 
major categories of such key genes. Thus, investigation of their functions under podocyte 
health and damage conditions can answer handfuls of questions in the context of FSGS.   
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Table 3-1: Genetic causes of FSGS and/or nephrotic syndrome.  
 Gene Protein Function Phenotype 
NPHS1 Nephrin 
Podocyte slit 
diaphragm 
Congenital nephrotic 
syndrome Finnish type, 
      
sporadic FSGS or nephrotic 
syndrome 
CD2AP 
CD2-associated 
protein 
Podocyte slit 
diaphragm 
Autosomal-dominant or 
autosomal-recessive 
      sporadic adult-onset FSGS 
NPHS2 Podocin 
Podocyte slit 
diaphragm 
Early onset autosomal-
recessive FSGS 
ACTN4 α-actinin-4 
Podocyte 
cytoskeleton 
Adult onset autosomal-
dominant FSGS 
MYO1E 
Unconventional 
myosin 1E Actin function 
Early onset autosomal-
recessive FSGS 
INF2 Inverted formin-2 Actin regulation Adult onset FSGS 
PTPRO 
Receptor-type 
tyrosine-protein Podocyte signalling 
Autosomal-recessive 
childhood FSGS 
  phosphatase 0*     
ARHGDIA 
Rho GDP-
dissociation inhibitor 
1 
Rho GTPase 
signalling, 
Early onset nephrotic 
syndrome or FSGS 
    actin dynamics   
TRPC6 
Transient receptor 
potential 
Calcium channel, 
podocyte 
Autosomal-dominant or 
autosomal-recessive 
  channel 6 mechanosensing sporadic adult onset FSGS 
WT1 Wilms tumour protein 
Podocyte 
development 
Autosomal-dominant 
sporadic FSGS, diffuse 
      mesangial sclerosis 
PLCE1 Phospholipase Cε1 
Podocyte 
differentiation, 
Early onset autosomal-
recessive FSGS 
    signalling 
or diffuse mesangial 
sclerosis 
LMX1B 
LIM homeobox 
transcription 
Podocyte and GBM 
development 
Nail–patella syndrome, rare 
FSGS 
  factor 1-β     
CD151 CD151 antigen 
Podocyte and 
GBM, laminin– 
Early FSGS, deafness, β-
thalassemia 
    integrin interactions   
LAMB2 Laminin B2 chain 
Interacts with 
integrin α3β1 , 
Autosomal-recessive 
Pierson syndrome 
    
links GBM to actin 
cytoskeleton or FSGS 
ITGB4 Integrin β4 
Cell–matrix 
adhesion Rare FSGS 
SMARCAL
1 
SWI/SNF-related 
matrix-associated 
Chromatin bundling 
and 
Autosomal-recessive 
Schimke immunoosseous 
 
actin-dependent 
regulator of gene transcription dysplasia, childhood FSGS 
  
chromatin subfamily 
A-like protein 1     
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COQ2 Polyprenyltransferase 
Mitochondrial 
function, deficient 
Autosomal-recessive early 
onset nephrotic 
    Coenzyme Q10 syndrome or FSGS 
COQ6 
Ubiquinone 
biosynthesis 
Ubiquinone 
biosynthesis 
Autosomal-recessive 
nephrotic syndrome, 
  
monooxygenase 
COQ6   FSGS, deafness 
PDSS2 
Decaprenyl 
diphosphate 
synthase 
Coenzyme Q10 
synthesis, FSGS or collapsing FSGS 
  subunit 2 
mitochondrial 
function   
ADCK4 
AarF domain-
containing protein 
Coenzyme Q10 
modulation FSGS 
  kinase 4     
MTTL1 
Mitochondrially 
encoded tRNA Mitochondrial tRNA 
Autosomal recessive 
MELAS or FSGS 
  leucine 1     
SCARB2 
Scavenger receptor 
class B 
Putative lysosomal 
receptor FSGS or collapsing FSGS 
  member 2     
APOL1 Apolipoprotein L1 Function unknown 
Risk of FSGS, collapsing 
FSGS or HIVAN 
Adopted from (Fogo, 2015) 
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3.2 Transcriptional regulation 
The genome is a dynamic gamut of 3-D chromatin ranging from accessible to inaccessible 
states. (Shema et al., 2019) Chromatin accessibility is defined by the interplay between 
different chromatin and histone modifications in one hand and transcription factor (TF) 
binding on the other. (Figure 3.4) (Mason and Vondriska, 2019; Soufi et al., 2015)  
 
Figure 3.4: Controlling chromatin accessibility and transcription is governed by several factors. 
Nucleosomes are structural units of chromatin comprised of different histone subtypes (octamer 
complex including one pair of: H2A, H2B, H3 and H4). Different chromatin and histone modifications 
can mobilize the nucleosome and shuffle the chromatin between inaccessible (heterochromatin) and 
accessible (euchromatin) states. TF: transcription factor. Figure adopted and modified from (Mason 
and Vondriska, 2019)  
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In eukaryotes, gene expression is the outcome of combinatorial function of cis- and trans- 
acting DNA elements which result in modifying the chromatin accessibility. (Kundaje et al., 
2015; Mathelier et al., 2015) Cis-acting DNA elements or cis-regulatory elements (CREs) are 
typically non-coding DNA sequences bearing binding sites for transcription factors and DNA 
regulatory molecules. The most popular CREs are promoters, enhancers, silencers and 
insulators. (Wittkopp and Kalay, 2011) The trans-acting elements are transcription factors and 
DNA regulatory proteins required for the assembly of the transcriptional machinery on the cis-
regulatory elements. The trans-acting elements bind to cis-regulatory regions on accessible 
chromatin and modulate transcription of target genes. (Figure 3.5) 
 
Figure 3.5: Overview of cis- and trans-regulatory elements.  
Gene expression is the outcome of the interplay between cis- and trans-regulatory elements. Figure 
adopted and modified from (Mathelier et al., 2015) 
 
Transcription factors regulate gene expression in two levels; firstly, they bind to enhancers 
(more) and promoters (less) and secondly, they recruit co-activators and histone modifying 
enzymes to target regions. Both ways define chromatin accessibility and therefore play a 
crucial role to determine and maintain cell states. (Graf and Enver, 2009) 
Transcription factors comprise of 8% of the genes in human and nearly 49% of them are tissue 
specific. This explains why the gene regulatory landscape of most tissues is determined by the 
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expression level as well as functionality of their transcription factors. (Shema et al., 2019) 
Furthermore, it provides clues on why mutations in transcription factors are often deleterious. 
Conventionally, mutations in transcription factors are known to be associated with 
tumorigenesis and developmental syndromes in different organs. (Lambert et al., 2018) CDX2 
mutation in colorectal cancer (Salari et al., 2012), SOX2 mutation in esophageal squamous cell 
carcinoma (Bass et al., 2009), Lmx1b mutation in Nail-Patella Syndrome (Dreyer et al., 1998), 
Wt1 mutations in Denys-Drash Syndrome and Frasier Syndrome are only a few to name. 
(Klamt et al., 1998; Mueller, 1994) Figure 3.6 enlists only some of the human disease 
phenotypes raised by transcription factor dysregulation. 
 
Figure 3.6: Human disease phenotypes caused by TF dysregulation.  
Each bar represents genes contributing to the annotation. Values within bars indicate number of TFs 
associated with each annotation. The significance of the size of the intersection between the set of 
human TFs and the indicated gene sets is shown on the X axis. Figure adopted and modified from 
(Lambert et al., 2018) 
In kidneys, not only a handful of developmental syndromes and malignancies are attributed 
to transcriptional dysregulation, but also the onset or progression of chronic kidney disease 
(CKD) is associated with mutations in transcription factors and/or transcriptional re-
programming. (Hishikawa et al., 2018) Relevant examples of such event in podocytes is 
mutations in the Wt1 and Lmx1b genes which results in the development of podocyte injury 
and glomerular sclerosis.(Boyer et al., 2013; Iijima et al., 2012; Menke et al., 2003) 
Furthermore, solid evidence advocates the contribution of transcription factors in other forms 
of podocyte damage in which transcription factors are genetically intact. (Gebeshuber et al., 
2013; Zhou et al., 2008) Despite of the existing knowledge surrounding TF functions in 
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podocytes, it is still unclear how the podocyte TF network (re)programs podocytes in response 
to internal and/or external offenses.  
3.3 The podocyte transcription factor repertoire 
Cellular processes are mostly executed by proteins which function via cooperating with other 
proteins. (Marcotte et al., 1999) Transcription factors are not exempt from this general rule in 
that they must cooperate in their gene regulatory functions. (Lambert et al., 2018) 
Cooperative function is advantageous in a cell in different ways. First, transcription factors 
cooperation offers combinatorial regulation which, per se, sets the ground for higher number 
of individual expression states without the need to produce different types of transcription 
factors. (Kato et al., 2004) Second, cells enjoying combinatorial regulation are more likely to 
be able to maintain certain regulatory functions when a transcription factor is non-functional. 
(Tsankov et al., 2006)  
Analyzing Wt1ChIPseq in mice, our group was first to suggest podocytes enjoy an intricate 
network of transcription factors consisting of Wt1, Tead1, MAFB, Fox TFs, TCF21, LMX1B. 
(Figure 3.7) These transcription factors cooperate on podocyte-specific enhancers to drive 
their gene regulatory functions. (Kann et al., 2015) It is yet unknown which key podocyte 
pathways are co-directed by these master transcription factors. 
 
 
Figure 3.7: Wt1-dependent transcriptional network in podocyte.  
Wt1 cooperatively binds to podocyte-specific enhancers. The podocyte transcription factor (TF) 
network consists of Wt1, Lmx1b, Fox family TFs, TCF family TFs, MAFB, etc. Figure adopted and 
modified from (Kann et al., 2015)  
The Wilm’s tumor 1 (Wt1) is an indispensable transcription factor for podocyte development 
and function. Mutations in Wt1 lead to different renal diseases ranging from severe congenital 
14 
 
disorders (such as Wilm’s tumor or nephroblastoma, Denys-Drash syndrome, Frasier 
syndrome) to less severe but yet persistent and compelling disorders (such as minimal change 
disease and FSGS). (Baird et al., 1992; Klamt et al., 1998; Pelletier et al., 1991; Ruf et al., 2004) 
TEAD transcription factor family is encoded by different genes and varying expression profiles 
in different tissues. (Gibault et al., 2018) TEADs act as downstream mediators of Hippo 
pathway which is well-known for its role in regulation of organ growth. (Ma et al., 2019) 
Although a fair amount of literature exists on the role of Wt1 and Tead1 in podocytes, the 
knowledge surrounding how these two transcription factors drive the cellular machinery in 
podocytes under healthy and damage conditions is still in its infancy. In this thesis, ChIP 
sequencing and RNA sequencing techniques are employed together with numerous data 
analysis approaches to uncover the gene regulatory networks governed by Wt1 and Tead1.   
3.4 Transcriptomic analysis in kidneys 
In the context of transcriptional regulation, transcriptomic analysis links genomic features to 
gene function. In this sense, gene regulation studies are incomplete without a proper 
assessment of gene expression. In the past decades, RNA sequencing of a number of cells or 
tissue samples (bulk RNA) was the most precise approach to study RNA expression dynamics. 
However, unraveling the cell-type specific transcriptome was a longstanding enigma until the 
introduction of high resolution single-cell RNA sequencing in 2009. (Tang et al., 2009) Over the 
past decade, successive methodological developments have been introduced to the field, all 
of which are directed to explore cell type diversity within a tissue. (Svensson et al., 2018)  
In the field of kidney research, several groups have directed their focus on using single cell 
RNA sequencing to answer hundreds of existing questions. Single cell transcriptomic of whole 
kidney from healthy mice suggests the existence of a novel transitional cell type which is 
mainly governed by Notch signaling. Employing the technique, authors claim that hereditary 
kidney disease with same pathological characteristics are likely to be originated from the same 
differentiated type of cells. (Park et al., 2018) In another study, single cell RNA sequencing of 
mouse developing kidneys shows that in the initial phases of nephrogenesis, single cell 
transcriptome signatures display several cellular pathways. During lineage specification, 
combinatorial gene repression and activation determines cellular fate in kidneys. (Brunskill et 
al., 2014) A separate study reveals a signaling crosstalk between the three main cell types of 
the collecting ducts using single cell RNA sequencing of mouse collecting duct cells. (Chen et 
al., 2017)  
Despite all such studies, an exhaustive characterization of glomerular cells was still missing. 
The function of glomeruli is central in the kidney filtration apparatus. Glomerulus is composed 
of three main cell types: podocytes, endothelial cells and mesangial cells. Glomeruli are 
constantly exposed to physiological signals such as fluctuating blood shear stress along the 
capillaries and intra/extra cellular mechanical strain. In normal healthy kidneys, glomerular 
cells adapt themselves to the changing blood pressure and mechanical strain. Glomerular 
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disease is often accompanied by a dysregulated response to such stimuli. While the 
glomerular cell types have been identified for decades now, it remains unclear whether 
physiological cues induce individual cell response within the glomerulus. In this thesis, the 
glomerular cell type heterogeneity in wildtype mice is investigated using single-cell RNA 
sequencing. This technique offers a high-throughput transcriptome profiling of individual cells 
to identify cell-type subsets as well as novel markers of known cell populations. 
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4 Aims of thesis 
Podocyte homeostasis is governed by the coordinated actions of an intricate network of 
transcription factors as well as epigenomic regulators. When compromised, podocytes 
undergo extensive characteristic changes leading to malfunctioning of these cells within the 
filtration apparatus of the kidneys. If such condition is persistent, it is often accompanied by 
proteinuria and the loss of podocytes leaving a scar behind. This is known as focal segmental 
glomerulosclerosis (FSGS), a common phenomenon in majority of the glomerular disease. If 
progressed, the disease of the glomeruli can lead to the loss of renal function. The existing 
knowledge about the gene regulation in podocytes is still missing key aspects in healthy 
podocytes let alone upon podocyte damage. Therefore, any palliative/curative attempt at the 
bedside depends on an exhaustive knowledge on the key regulators of gene expression in 
podocytes. This doctoral thesis is an attempt to unravel some but not all aspects of the gene 
regulatory networks in podocytes. To this end, this doctoral thesis covers the following three 
specific aims: 
1- Characterization of Wt1-dependent gene regulatory network in a hereditary mouse 
model of FSGS (Wt1 het del mice)  
There are numerous studies on the role of Wt1 in podocyte development and 
homeostasis. (Morrison et al., 2008) Our lab was first to investigate the Wt1-
dependent gene regulatory network in healthy podocytes in vivo. Wt1 cooperates with 
a panel of other TFs to govern podocyte-specific transcriptome in normal physiological 
conditions. (Kann et al., 2015) Of note, reduced levels of Wt1 is involved in the 
pathogenesis of FSGS. (Guo et al., 2002; Iijima et al., 2012) However, it is not known 
which Wt1-dpenedent gene regulatory circuits are involved in the development and 
progression of FSGS. In this thesis, Wt1 heterozygous deletion mouse model is used as 
a model for hereditary FSGS to investigate the role of Wt1 in the development and 
progression of podocyte disease. Differential binding on genomic features was 
assessed using chromatin immunoreaction followed by sequencing in the early phase 
of FSGS development. Differential gene expression was evaluated by RNA sequencing 
in early and late phases of FSGS and combined by the ChIPseq results to explore 
pathway perturbation in the course of disease. 
 
2- In vivo characterization of Tead1-dependent gene regulatory network in healthy male 
CD1 mice 
The studies surrounding the role of Hippo pathway in kidneys have mainly focused on 
the Yap and Taz transcriptional co-activators and cystic kidney disease. (Müller and 
Schermer, 2019; Rinschen et al., 2017; Wong et al., 2016) To date, no investigation is 
done on the role of TEADs in kidneys let alone in podocytes. In this thesis, chromatin 
immunoprecipitation followed by sequencing is performed in healthy male CD1 mice 
to unravel the Tead1-dependent gene regulatory network in podocytes. Moreover, 
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cooperative binding of Tead1 and Wt1 is assessed in genomic regions and the 
dependent functions of this cooperation is introduced.  
 
3- Characterization of glomerular cell transcriptome on a single cell resolution to address 
cell-to-cell diversity 
Glomeruli is composed of three main cell types: podocytes, endothelial cells and 
mesangial cells. However, the cellular heterogeneity of healthy glomeruli was not 
properly addressed to date. Using a nanodroplet-based highly parallel transcriptional 
profiling technique, the cellular features of isolated mouse glomeruli were re-
investigated. Furthermore, a new immunofluorescent staining approach was 
employed to validate the findings on protein level. 
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5 Materials and Methods 
5.1  Materials 
  Chemicals 
Table 5-1: List of chemicals, reagents and solutions 
Chemicals/reagents/solutions Product no. Provider 
1-Thioglycerol M1753 Sigma 
37% Formaldehyde Solution  4979.1 Th. Geyer GmbH 
Acetic Acid  49199  Sigma 
Bovine Serum Albumin A9418  Sigma 
Chloroform  1.02445.1000  Merck 
D1000 DNA Ladder 5067-5586 Agilent 
D1000 Sample Buffer 5067-5602 Agilent 
D-Fructose F0127 Sigma 
Dimethyl Sulfoxide (DMSO) A3672,0100  AppliChem 
Dithiothreitol (DTT)  R0862  Thermo Fisher 
dNTPs  R0182  Thermo Fisher 
Dulbecco’s Modified Eagle Medium (DMEM) D6429  Sigma 
Dynabeads M-450 tosylactivated 140.13  Invitrogen  
Ethanol absolute  9065  Carl Roth 
Ethidiumbromide solution 1% 2218  Carl Roth 
Ethylenediaminetetraacetic 
acid disodium salt dihydrate (EDTA)  
60-00-4  
 
Sigma 
Fetal Bovine Serum (FBS) 10270-106  Gibco 
Gelatin  4070 Merck 
Glutamax  35050-038  Gibco 
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Glycerol  3783  Carl Roth  
Glycine  3908.3  Carl Roth 
Glycogen G8751 Sigma 
Heparin  3862340  Rotexmedica 
Histomount  HS-103  National Diagnostics 
Isopropanol  5752.3  Carl Roth 
Ketamine hydrochloride solution (Ketavet) K-002 Merck 
Lipofectamine® RNAiMAX Transfection Reagent 13778150  Thermo Scientific 
Lithium Chloride 203637 Sigma 
Magnesium Chloride 1.05833.0250  Merck 
Magnetic Dynabeads 14203 Thermo Fisher Scientific 
Matrigel  356231 BD Bioscience  
Mayer’s Hematoxylin Solution MHS1 Sigma 
mCas9 mRNA L-6125-20 TriLink 
Methanol  4627 Carl Roth 
N,N,N´,N´tetramethylethylenediamine (TEMED) 2367  Carl Roth 
Periodic Acid 99%  3257  Carl Roth 
Phenol:Chloroform:Isoamyl Alcohol 25:24:1  P2069 Merck 
Polyacrylamide  T802  Carl Roth 
Potassium Chloride  6781  Carl Roth 
Power SYBR® Green PCR Master Mix 4368702  Invitrogen 
Protease inhibitors 11697498001 Roche 
Pure acetic acid 99% -100% 7332  Carl Roth 
REDTaq® ReadyMix™ PCR Reaction Mix R2523  Sigma 
RNA Screen Tape Sample Buffer 5067-5577 Agilent 
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RNase-free water Ultra-Pure 10977-035  Invitrogen 
Rompun 2%  DIN 02169592 Bayer 
Schiff's Reagent  1.090.330.500  VWR 
SDS pellets  CN30  Carl Roth 
Sodium Chloride  S5886  Sigma 
Sodium deoxycholate  D6750  Sigma 
Sodium hydrogen carbonate 106329  Merck 
Sodium hydroxide solution T135  Carl Roth 
Sodium(di-)hydrogenphosphate heptahydrate SIALS9390 Sigma 
Sodium(tetra-) diphosphate decahydrate 106591  Merck 
TRI Reagent 93289 Sigma 
Tris Base  T1503  Sigma 
Tris Hydrochlorid (HCl)  9090.3 Sigma 
Triton X-100 A4975,1000  Applichem 
Trypsin-EDTA Solution (1x)  T3924  Sigma 
Tween®20  3472  Caesar & Lorentz 
Vectashield Mounting Medium with DAPI H1200 Vector Laboratories 
Water PCR Reagent  R2523  Sigma 
Xylol >98%  0371.5000  Geyer 
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6 Kits and assays 
Table 6-1: List of kits and assays 
Name Product no. Provider 
Creatinine Urinary Colorimetric Assay 
Kit 
500701 Cayman  
DNA Screen Tape 5067-5582 Agilent 
GeneJet PCR purification kit K0702 Thermo Scientific 
High Capacity cDNA Reverse 
Transcription Kit 
4368814  
 
Applied Biosystems 
HiScribe T7 High Yield RNA Synthesis 
Kit  
E2040S New England Bio Labs 
miRNeasy Mini Kit  217004 Qiagen 
Mouse Albumin ELISA Kit E-90AL Immunology Consultants 
Laboratory  
RNA Screen Tape 5067-5576 Agilent 
RNeasy mini kit  74104  Qiagen  
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  Buffers and solutions 
Table 6-2: List of buffers and solutions 
Name Ingredients 
0.3mM NaCl RIPA  10 mM Tris-HCl pH 7.4 
300 mM NaCl 
1 mM EDTA 
0.1% Triton X-100 
0.1% SDS 
0.1% Sodium Deoxycholate 
0.4mM NaCl RIPA 10 mM Tris-HCl pH 7.4 
400 mM NaCl 
1 mM EDTA 
0.1% Triton X-100 
0.1% SDS 
0.1% Sodium Deoxycholate 
0M NaCl RIPA 10 mM Tris-HCl pH 7.4 
1 mM EDTA 
0.1% Triton X-100 
0.1% SDS 
0.1% Sodium Deoxycholate 
10x HBSS Solution 1  
 
 
5.4 mM KCl  
0.3 mM Na2HPO4 x 7H2O  
0.4 mM KH2PO4  
4.2 mM NaHCO3  
137 mM NaCl  
5.6 mM D-glucose  
Add ddH2O to 1 liter and adjust pH 
to 7.4 
filter sterilize and keep at 4°C 
10x HBSS Solution 2  
 
1.3 mM CaCl2 x 2H2O  
0.5 mM MgCl2 x 6H2O  
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0.6 mM MgSO4 x 7H2O  
Add ddH2O to 1 liter and keep at 
4°C 
1x HBSS  
 
100 ml 10x Solution 1  
100 ml 10x Solution 2 
Add ddH2O to 1 liter and keep at 
4°C  
250mM LiCl Buffer 250mM LiCl  
1mM EDTA  
10mM Tris-HCl pH 7.4   
0.5% NP-40   
0.5% Na-Deoxycholate   
in ddH2O 
500mM LiCl Buffer 500mM LiCl  
1mM EDTA  
10mM Tris-HCl pH 7.4   
0.5% NP-40   
0.5% Na-Deoxycholate   
in ddH2O  
Anesthesia Solution 
 
6.8 ml 0.9% NaCl  
1 ml 100mg/ml Ketavet 
0.4 ml Rompun 
Base Solution (1x)  
 
0.5 ml Base solution (50x) 
24.5 ml ddH2O  
pH 12 
Base Solution (50x)  
 
12.5 ml NaOH (5N) 
1 ml EDTA (0.5 M) 
36.5 ml ddH2O 
Chromatin Buffer 25% v/v 10% Triton X-100 
25% v/v 1% Deoxycholate 
25% v/v 1% SDS 
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25% v/v 1.4 M NaCl 
Clearing Solution 200 mM Boric Acid 
4% SDS pH 8.5 
Colloidal Coomassie Solution  
 
80% Colloidal Coomassie Stock 
solution  
20% (v/v) Methanol 
Colloidal Coomassie Stock Solution  
 
755 mM (NH4)2SO4  
2.55% (v/v) Phosphoric acid  
0.1% (w/v) Coomassie brilliant 
blue G250 
Fixing solution for Coomassie  
 
25% (v/v) Isopropanol  
10% (v/v) Acetic Acid 
Hydrogel Solution 4% v/v Acrylamide 
0.25% w/v VA-044 initiator 
PBS 1X 
Laemmli Sample Buffer (2x)  
 
100 mM Tris  
4% (w/v) SDS  
20% (v/v) Glycerol  
Bromphenol Blue  
100 mM DTT  
pH 6.8 
Neutralization Solution (1x)  
 
0.5 ml of stock sol. 50X 
24.5 ml ddH20  
pH 5 
Neutralization Solution (50x)  
 
15.75 g Tris-HCl 
in 50 ml of ddH2O 
Nuclei Lysis Buffer 50 mM Tris-HCl pH:8   
10 mM EDTA    
0.5% SDS 
in ddH2O 
PBST  0.1% Triton-X  
25 
 
1X PBS 
Permeabilization Buffer 0,35 g Gelatin  
50 ml PBS with Ca2+ and Mg2+  
0.5% Triton-X 
Running Buffer  
 
25 mM Tris  
192 mM Glycine  
0.1% (w/v) SDS 
SDS Elution Buffer 1% SDS  
10mM EDTA   
50mM Tris-HCl pH 7.4 
in ddH2O  
Sonication Buffer 1mM DTT 
0.25% Sarcosine 
1x 0.3mM NaCl RIPA 
Stacking Gel  
 
250 mM Tris 
5% (v/v) PAA 
0.2%(w/v) SDS 
pH 6.8 
TAE (1x)  
 
40 mM Tris  
20 mM Acetic Acid  
1 mM EDTA 
pH 8.5 
Tail Lysis Buffer  0.2% SDS 
100 mM Tris pH: 8.5 
5 mM EDTA 
200 mM NaCl 
in 50 ml of ddH2O 
TE Buffer 1mM EDTA   
10mM Tris-HCl pH 7.4 
in 50 ml of ddH2O  
26 
 
  Oligonucleotides 
Table 6-3: List of oligonucleotide sequences 
Primer name Sequence (5'->3') 
Bmp7 fp (ChIP-qPCR) TACAAGTCCGGAGAGCGAGT 
Bmp7 rp (ChIP-qPCR) AGATCGGAAAGGGGTTTGTT 
Cre fp (genotyping PCR) GCATAACCAGTGAAACAGCATTGCTG 
Cre rp (genotyping PCR) GGACATGTTCAGGGATCGCCAGGCG 
Flag-Tead1 fp (CRISPR T7 assay) CTTACTATGCAGCTTGTAGAAGCAGTATATT 
Flag-Tead1 rp (CRISPR T7 assay) CCCTGAAAGGAATGTTCCAGGCCACTTACCATAC 
Flag-Tead1 transgenic fp (genotyping PCR) GACTACAAAGACGATGACGACAAGGGC 
Flag-Tead1 transgenic rp (genotyping PCR) CCCTGAAAGGAATGTTCCAGGCCACTTACCATAC 
Flag-Tead1 wildtype fp (genotyping PCR) TCTGTCTCCCACTACTGCATCTTG 
Flag-Tead1 wildtype rp (genotyping PCR)  GTCGCTCATCCTTTCCATGT 
Fyn fp (ChIP-qPCR) AAATAGGAATTGGCTTGGGG 
Fyn rp (ChIP-qPCR) GGGAGGTTCCAGAAATAGGC 
GAPDHs fp (ChIP-qPCR) CAGGAGCCCAGGGAAGATACAAATA 
GAPDHs rp (ChIP-qPCR) ACGCATACACATATACAACCAGTCA 
Gas1 fp (ChIP-qPCR) CCGCGAGGCTTTAAATACAA  
Gas1 rp (ChIP-qPCR) CGGAGAGTGGAGAAAGGAGA 
Jmjd1a fp (ChIP-qPCR)  GCAGCTCCATTCTTCCATTT 
Jmjd1a rp (ChIP-qPCR) GCTCATGATCCTGGGTCTC 
Lats2 fp (ChIP-qPCR)  GCGGCGGCTCCATCTTCC 
Lats2 rp (ChIP-qPCR) GGAGTGACGCGGGAGGAG 
mTmG transgenic rp (genotyping PCR) TCAATGGGCGGGGGTCGTT 
mTmG wildtype fp (genotyping PCR) CTCTGCTGCCTCCTGGCTTCT 
27 
 
mTmG wildtype rp (genotyping PCR) CGAGGCGGATCACAAGCAATA 
Nphs1-Peak1 fp (ChIP-qPCR) AAGAGAGAAGGGCGAGTTAG 
Nphs1-Peak1 rp (ChIP-qPCR) AATCAGGTGGCAAGTTCTG 
Nphs1-Peak2 fp (ChIP-qPCR) AGTTGACCCAGTGGTTACG 
Nphs1-Peak2 rp (ChIP-qPCR) TGGCGCTCAGCTTCTTAG 
Nphs2 fp (ChIP-qPCR) ATGGTGGGGAGGAGAAGG 
Nphs2 rp (ChIP-qPCR) TGAACCCGGTCCTAAACAAC 
ß-globin fp (genotyping PCR) TGCTCACACAGGATAGAGAGGGCAGG  
ß-globin rp (genotyping PCR) GGCTGTCCAAGTGATTCAGGCCATCG 
Sulf1 fp (ChIP-qPCR) TGCTCCTCCTCTTCTTGGAA 
Sulf1 rp (ChIP-qPCR) GATAAAACTGCCCGACCTGA 
Synpo fp (ChIP-qPCR) AGGTCCTTCTGGGGAAAG  
Synpo rp (ChIP-qPCR) TGGTCATAGGCTGATCCC 
Vegfa fp (ChIP-qPCR) AAGCTAGAGCGGTGGGAGAG 
Vegfa rp (ChIP-qPCR) CTTTGCTGTCACTGCCGTTT 
Wt1 PKG rp (genotyping PCR) CCATTTGTCACGTCCTGC 
Wt1 wildtype fp (genotyping PCR) GTGACCCGGCAGCTAGCC 
Wt1 wildtype rp (genotyping PCR) GGAGCGTTCATCTCGGAGAC 
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 Antibodies and enzymes 
Table 6-4: List of antibodies and enzymes 
Name Product no. Provider 
Cald1  HPA008066 Sigma 
Collagen IV  ab6586 Abcam 
Collagenase II LS004177 Worthington 
Deoxyribonuclease I A3778 Applichem  
EphB1 PAB3018 Abnova 
EphrinB1  AF473 R&D Systems 
Go Taq Flexi DNA Polymerase  M7808 Promega 
Lars2 ab187983 Abcam 
mCas9  1074181 Integrated DNA Technologies 
Nephrin  AF4269 R&D Systems 
Nephrin 20R-NP002 Fitzgerald 
Normal Goat IgG sc-2028 Santa Cruz 
Normal Mouse IgG sc-2025 Santa Cruz 
Normal Rabbit IgG sc-2027 Santa Cruz 
Podocin  P0372 Sigma-Aldrich 
Protease from Streptomyces griseus A3459 Applichem 
Proteinase K 82456  Sigma 
T7 Endonuclease I M0302S New England Bio Labs 
Tead1 610922 BD Biosciences 
Wt1  ab89901 Abcam 
Wt1 sc-192 Santa Cruz 
β1-integrin  9EG7 BD Biosciences 
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  Equipment 
Table 6-5: List of equipment 
Name Product no. Provider 
7900HT Fast Real-Time PCR System 4351405 Thermo Fisher 
Scientific 
8-well µ-Slide 80826 ibidi 
Cell Strainer, 100µm 10199-658 VWR 
Cell Strainer, 40µm 10199-655 VWR 
Cycler  S1000  BIO-RAD 
Dumont #5 forceps  14098 WPI 
Dumont #55 forceps  14099  WPI 
DynaMag Magnet  12321D Thermo Fisher 
Scientific 
EnSpire Multimode Plate Reader  2300-0000  Perkin Elmer  
Eppendorf LoBind microcentrifuge tubes Z666521 Sigma 
Fast thermal cycling 96- well plates 4346907  Applied Biosystem 
Focused-ultrasonicator M220 Covaris 
Gel cassette 1mm  NC2010  Invitrogen 
Glass bottom dish  P35G-1.5-14-C MatTek 
Glass cuvette  631-9511  VWR 
Heating block  TH 21  Ditabis 
Horizontal electrophoresis system  L 40-1214 PeqLab 
Horizontal electrophoresis system   S 40-0708 PeqLab 
Incubator  BD 115  Binder 
Incubator (cell culture)  MCO-20AIC  Sanyo 
Leica SP8  -  Leica   
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Micro tubes (1.5ml)  72.690.001  Sarstedt 
Microcentrifuge  5421  Eppendorf 
Microtome  RM2235  Leica 
Multichannel pipette  316-3706  VWR 
Nanodrop Spectrophotometer  1000  PeqLab 
Odyssey CLx Imager - LI-COR Inc 
Office scanner  C224e  Konica Minolta  
Operating scissor 501754  WPI 
Phase Lock Gel microcentrifuge tubes 733-2478 5Prime 
Pipetteboy acu  613-4438  Integra 
Pipettetes: Research plus 3Pack Option 1  613-1143  Eppendorf 
Polypropylene conical tube (15 ml) 734-0451 VWR  
Polypropylene conical tube (50 ml) 734-0448 VWR 
Rotiabo®-syringe filters, 0.22µm P666.1  Carl Roth  
Rotiabo®-syringe filters, 0.45µm P667.1  Carl Roth  
Safe Lock 1.5ml Eppendorf tubes 301 23 328  LMS 
Slidescanner  SCN400  Leica 
STED superresolution and confocal 
microscope 
- Leica 
Sterile hood  Mars Safety Class 2 SCANLAF 
Stripettes (10 ml) 4101 LMS 
Stripettes (25 ml) 4251 LMS 
Stripettes (5 ml)  4051  LMS 
Suction pump  181-0067DE  VWR 
Suction pump (cell culture)  HLC  DITABIS  
SuperFrost®/Plus microscope slides H867.1  Th.Geyer Group 
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Syringe (1ml)  7392/2007  BD 
Thermoshaker  444-0823  Grant 
TipOne (0.1-10 µl XL), sterile S1110-3810-c  Starlab 
TipOne 101-1000µl graduated, sterile  S1111-2831-c  Starlab  
TipOne 1-200µl beveled, sterile S1111-1816-c  Starlab 
UV Transilluminator system - INTAS UV-System 
Vannas Scissors  500086  WPI 
Vortex Mixer  444-1372  VWR 
Water bath  HBR4  IKA 
Water bath (for paraffin sections)  HI1210  Leica 
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 Software 
Table 6-6: List of software 
Software Version no. Provider 
Adobe Illustrator 22.0.1 Adobe 
Adobe Photoshop  11.0 Adobe 
DataAssist  3.01  Applied Biosystems  
GraphPad Prism 5 for Windows 6.05  GraphPad Software Inc. 
ImageJ/Fiji  - Wayne Rasband  
ImageScope  12.0.1.5030  Aperio  
ImageStudio  5.2  LI-COR  
LAS X software  3.1.5 Leica Microsystems, Wetzlar, Germany 
LSM Software  - Zeiss 
Mausoleum  6.6.1  H.E. Stöffler 
Microsoft Office Suite  2010  Microsoft  
Nanodrop 1000  3.7  Thermo Scientific  
QuPath 0.1.2 Queen's University Belfast 
SDS Software  2.4  Applied Biosystems 
TapeStation A.02.01 Agilent Technologies 
ZEN Software  2009  Zeiss  
Zotero 5.0.74 - 
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6.2  Methods 
 Cell culture  
6.2.1.1 Culture of immortalized cell lines 
Monolayer cultures of cells were maintained in their respective media at 37°C under 5% CO2 
condition. Inner mouse collecting duct (mIMCD3) cells were cultivated in DMEM:F12 media 
supplemented with 10% FBS and 1x Glutamax to optimize the Tead1ChIPseq protocol. Mouse 
Motor Neuron (NSC-34) cells were cultivated in DMEM media supplemented with 10% FBS 
and 1x Glutamax to perform cell transfection for CRISPR/Cas9 mediated genome editing.  
For passaging, cells were washed with 1x PBS without Ca2+ and Mg2+ and trypsinization was 
complete by adding 1 ml Trypsin for 2-5 min at 37°C. The reaction was stopped by addition of 
media and the cells were seeded in a sterile 10-cm culture dish with pre-warmed media in 
desired ratios for mIMCD3 and NCS34 cells, respectively. Cells were passaged two times per 
week to maintain the line and they were only passaged up to 10 times to avoid abnormal cell 
growth and morphology. Table 6-7 enlists the cell lines used during this thesis. 
Table 6-7: List of cell lines 
Name of the cell line Provider 
mIMCD3 (Mouse Inner Medullary Collecting Duct Cells) Nephrolab, Cologne 
NSC-34 (Mouse Motor Neuron-like cells) Nephrolab, Cologne 
 
6.2.1.2 Freezing and thawing of cells 
For freezing, cells were washed with 1x PBS without Ca2+ and Mg2+. After trypsinization, cells 
were re-suspended in 9 ml of fresh pre-warmed media and centrifuged for 5 min at 1000 rpm 
at 4°C. The pellet was re-suspended in 1 ml freezing medium containing 45% DMEM, 45% FBS 
and 10% DMSO. Cells were quickly transferred into a cryovial and gradually frozen in a freezing 
chamber at -80°C. For thawing, cells were thawed by dipping the cryovials in pre-warmed 
water bath at 37°C for 1 min and the cell suspension was mixed with 5 ml fresh media. After 
centrifugation for 5 min at 1000 rpm at 4°C, the cell pellets were re-suspended in 9 ml pre-
warmed fresh media and seeded in a sterile culture dish accordingly. 
6.2.1.3 Co-transfection with mCas9 and gRNA 
For transfection, cells were grown to a confluency of 50% in 6-well sterile culture dishes and 
transfected with Lipofectamine RNAimax (final concentration: 20 nM), gRNA (total amount: 
700 µg) and mCas9 RNA (total amount: 1ug/ul). Transfected cells were incubated for 24-48 h 
and then trypsinized to perform the T7 endonuclease I assay.  
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 CRISPR/Cas9-mediated genome editing  
6.2.2.1 Design and production of small guide RNA 
In silico guide RNA design was performed in Benchling using the following settings: NGG was 
assigned as the desired Protospacer Adjacent Motif (PAM) sequence and the sgRNA length 
was adjusted to 20 nucleotides. The sequence for the gene of interest was queried using the 
Mus musculus reference genome mm10. Aiming for insertion of a single Flag-tag after the 
start codon, a region spanning approximately 100 bp around the start codon was selected as 
input for the gRNA design algorithm in Benchling. Best-matching oligo template was selected 
and a 60-bp custom oligo was ordered containing the following elements (5'->3') 
1- T7 RNA polymerase recognition sequence (TTAATACGACTCACTATAGG) 
2- 20-bp oligo template (NNNNNNNNNNNNNNNNNNNN) 
3- Cas9 recruiting sequence (GTTTTAGAGCTAGAAATAGC) 
sgRNA was generated in vitro using T7 RNA polymerase and pSpCas9(BB)-2A-Puro (PX459) 
V2.0 plasmid (Addgene # 62988) from Feng Zhang’s lab and purified using miRNeasy Mini Kit. 
(Ran et al., 2013) Table 6-8 enlists all the designed guide RNAs. The Tead1 sgRNA has been 
used in this thesis and the other three sgRNAs are designed for other projects.  
Table 6-8: List of designed guide RNA 
Gene of interest gRNA sequence 
KLF15 TTAATACGACTCACTATAGGGCTCGGCCAGGCCAGCATGGGTTTTAGAGCTA
GAAATAGC 
MafB TTAATACGACTCACTATAGGCTCGCTTTTAGCGATGGCCGGTTTTAGAGCTA
GAAATAGC 
TCF21 TTAATACGACTCACTATAGGACCTCTCTAAACATGTCCACGTTTTAGAGCTAG
AAATAGC 
Tead1 TTAATACGACTCACTATAGGGCCCTGCCGAAAACATGGAAGTTTTAGAGCTA
GAAATAGC 
 
6.2.2.2 T7 endonuclease I assay 
Genomic DNA from transfected NCS34 cells was extracted using the HotSHOT exctraction 
method. (Truett et al., 2000) In brief, samples were incubated in 50-150 µl Base solution for 
30min at 95°C followed by incubation on ice for 5 minutes. The reaction was stopped by 
addition of 50-150 µl Neutralization solution. PCR was run using REDTaq® ReadyMix™ PCR 
reaction mix and two primers flanking the sgRNA region to amplify a window of 300-500 bp. 
The PCR products were purified using GeneJet PCR purification kit and 200 ng of the purified 
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DNA was incubated for hybridization reaction. Table 6-9 enlists the reaction composition and 
the cycling conditions used for hybridization reaction. 
Table 6-9: Hybridization reaction reagents and cycling conditions 
Reaction mix Step Cycling condition 
DNA 200 ng 
10X NEBuffer 2 2 µl  
Nuclease-free Water To 19 µl 
Initial denaturation 
Annealing (Ramp 
rate) 
Final hold 
95°C   5 min 
95-85°C -2°C/second  
85-25°C -0.1°C/second 
4°C    forever 
 
After this step, T7 endonuclease I reaction was performed using half of the product according 
to the manufacturer’s protocol. The remaining DNA was kept as a negative control. T7 assay 
product was ran on a 2% agarose gel together with the negative control. Table 6-10 enlists the 
PCR reaction composition and the cycling conditions used for T7 endonuclease I assay.  
Table 6-10: PCR reaction reagents and cycling conditions 
Reaction mix Step Cycling condition 
1x Red Taq Sigma master mix 
1 pM fp  
1 pM rp 
~ 50 ng DNA 
Add H2O to 20 µl  
 
Initialization  
Denaturation  
Annealing   
Extension  
 
Final extension  
Final hold 
95°C    5 min 
95°C    60 s 
60°C    60 s 
72°C    90 s 
go to step 2, repeat 29 times 
72°C    10 min 
15°C    forever 
 
6.2.2.3 Designing single-stranded oligonucleotide donor (ssODN) 
ssODN was designed complementary to the strand from which the sgRNA was designed. The 
ssODNs were designed asymmetrical and contained <200 nucleotides to increase the 
efficiency of the homology directed repair (HDR) according to the latest literature to date. 
(Richardson et al., 2016) The Flag sequence (GACTACAAAGACGATGACGACAAG) followed by a 
flexible spacer (GGCGGAGGGGGAAGC) was inserted between the short and long homology 
arms. Custom-made ssODNs were ordered from Integrated DNA Technologies. Table 6-11 
enlists all the designed ssODNs. The Flag-Tead1 ssODN has been used in this thesis and the 
other three ssODNs are designed for other projects. 
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Table 6-11: List of designed ssODN 
Gene of interest ssODN sequence 
Flag- Tead1 GGGCCTCCTGGAAACTCTGCTCAATATCAGGACTCCAGACGCCCTCCGCGTC
GTTGTCAATCGGCTTATCTGCCGAGTCGCTCATCCTTTCGCTTCCCCCTCCGC
CCTTGTCGTCATCGTCTTTGTAGTCCATGTTTTCGGCAGGGCTCTCGCTGCCG
CTCCAGCT 
Flag-KLF15 GTATGGCTGCCGGCTGGCCAGCCTGTCCCCTAGGTAACCCACTGAGCATTTC
GGTGACGAGAAGGTCTCGTCCACTGGAAGCAGGTGGTCCACGCTTCCCCCT
CCGCCCTTGTCGTCATCGTCTTTGTAGTCCATGCTGGCCTGGCCGAGCCTGTG
GTGACTGCAGAG 
Flag-MafB TCACGTCGAACTTGAGAAGGTCGAAGTCGTTGACGTACTCCATGGCCAGCG
GGCTGGTGGGCAGCTCTTGCCCCATGCTCAGCTCCGCGGCGCTTCCCCCTCC
GCCCTTGTCGTCATCGTCTTTGTAGTCCATCGCTAAAAGCGAGGCTCAGCCG
CCGCTGCCGCG 
Flag-TCF21 TCCAAACTCCTTGTTGGAGTCCACTTTCAGGGAGTCACAGTCCAGCATCTCCA
CCTCTTGAAGGTCTTCTACATCGCTGAGGGAGCCAGTGGAGCTTCCCCCTCC
GCCCTTGTCGTCATCGTCTTTGTAGTCCATGTTTAGAGAGGTGGAGGGAGG
GAGGGA 
 
6.2.2.4 Electroporation of zygotes 
After validating steps, CRISPR/Cas9 components were submitted to the in vivo Research 
Facility, University of Cologne for generation of Flag-Tead1 transgenic mice using 
Easy Electroporation of Zygotes (EEZy) method in C57BL/6J mice. (Tröder et al., 2018) The 
EEZy reaction mix consists of mCas9 mRNA (final concentration: 50ng/µl), sgRNA (final 
concentration: 50ng/µl), template DNA or ssODN (final concentration: 100ng/µl) and mCas9 
protein (final concentration: 30ng/µl).  
To test the target recombination in F0 mice, a genotyping PCR was done on the extracted DNA 
from mice ear tags using previously discussed primers. The amplicons were checked on a 2% 
agarose gel to find the expected bands. The rest of the PCR product was used for topo cloning 
reaction according to the standard protocol provided by the manufacturer. After completion 
of the topo cloning reaction, chemical transformation of the clones into competent E. coli 
DH10B was done. Isolation of DNA from mini cultures was completed using GeneJet Plasmid 
Miniprep Kit and the DNA was further processed for sequencing.  
6.2.2.5 Sanger sequencing 
To confirm the expected recombination, all inserts were sequenced using the BigDye 
Terminator v3.1 Cycle Sequencing Kit. Each sequencing reaction consisted of 150 ng DNA, 2 
pmol of the sequencing primer primer, 0.25 µl BigDye Terminator, 2.25 µl sequencing buffer 
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to a final reaction volume of 10 µl. Cycling steps were as follows: 1 min at 96°C, (10 s, 96°C; 5 
s, 55°C) for 40 cycles and 4 min at 60°C. DNA was submitted to the Cologne Center for 
Genomics (CCG, Cologne, Germany) for Sanger sequencing. Sequence alignment and 
comparison of the results with the initially designed insert was performed in Benchling.  
 Mouse experiments 
6.2.3.1 Mouse lines 
All the mouse lines for this thesis were housed based on standardized specific pathogen-free 
conditions in the in vivo Research Facility of the University of Cologne. All mouse experiments 
were carried out within the guideline frame provided by the LANUV NRW (Landesamt für 
Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen/State Agency for Nature, 
Environment and Consumer Protection North Rhine-Westphalia) and were approved by the 
same Institution.  
6.2.3.2 DNA extraction from mouse tissue 
Ear or tail biopsies were used to extract genomic DNA using the HotSHOT method for Flag-
Tead1 and Nphs2Cre x mTmG mice. For Wt1 het del mice, Proteinase K-mediated genomic DNA 
extraction method was used. In brief, biopsies were lysed in Tail Lysis Buffer supplemented 
with Proteinase K (final concentration: 0.1 mg/ml) at 60°C overnight. Extracted DNA was 
recovered the next day using Isopropanol and re-suspended in TE buffer. 
6.2.3.3 Polymerase chain reaction for genotyping 
REDTaq® ReadyMix™ PCR reaction mix and Go Taq Flexi DNA Polymerase 5U/µl were used for 
genotyping PCR reaction according to the manufacturer’s protocol. Table 6-3 enlists the 
specific primer sequences for the genotyping PCRs. Detailed PCR reaction composition as well 
as cycling conditions for all primer pairs are listed in the Table 6-12 and Table 6-13, 
respectively.  
Table 6-12: Genotyping PCR reaction reagents 
Gene name Reaction mix 
Cre  1x Red Taq Sigma master mix 
1.25 pM Cre fp  
1.25 pM Cre rp  
1.25 pM ß-globin fp  
1.25 pM ß-globin rp 
~ 50 ng DNA 
Add H2O to 25 µl  
Flag-Tead1 1x Green Flexi Buffer 
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1.5 mM MgCl2  
0.2 mM dNTP (each) 
1.25 pM Flag-Tead1wildtype fp  
1.25 pM Flag-Tead1 wildtype rp 
1.25 pM Flag-Tead1transgenic fp 
1.25 pM Flag-Tead1transgenic rp 
~ 50 ng DNA 
0.2 Units Taq polymerase 
Add H2O to 25 µl 
mTmG 1x Green Flexi Buffer 
1.5 mM MgCl2  
0.2 mM dNTP (each) 
25 pM mTmG wt fp  
17 pM mTmG wt rp  
33 pM mTmG tg rp  
~ 50 ng DNA 
0.2 Units Taq polymerase  
Add H2O to 25 µl 
Wt1 1x Green Flexi Buffer 
1.5 mM MgCl2  
0.2 mM dNTP (each) 
1.25 pM Wt1 het del fp  
1.25 pM Wt1 het del rp 
1.25 pM Wt1 het del PKG cassette rp 
~ 50 ng DNA 
0.2 Units Taq polymerase 
Add H2O to 25 µl 
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Table 6-13: List of PCR cycling conditions and the product sizes 
Gene name Step Cycling condition Product size 
Cre Initialization  
Denaturation  
Annealing   
Extension  
 
Final extension  
Final hold 
94°C….3 min  
94°C….45 s  
59°C….60 s  
72°C….45 s → go to step 
2, repeat 30 times  
72°C….10 min 
10°C…. forever 
Internal control band: 
494 bp 
Transgenic band: 269 bp 
Flag-Tead1 Initialization  
Denaturation  
Annealing  
Extension  
 
Final extension  
Final hold 
94°C….2 min 
94°C….20 s 
55°C….15 s 
72°C….1 min → go to 
step 2, repeat 34 times 
72°C….10 min 
15°C…. forever 
Wildtype band: 586 bp 
Transgenic band: 222 bp 
mTmG Initialization  
Denaturation  
Annealing  
Extension  
 
Final extension  
Final hold 
94°C….3 min  
94°C….30 s  
61°C….60 s  
72°C….60 s → go to step 
2, repeat 35 times  
72°C….120 s 
10°C…. forever 
Wildtype band: 330 bp 
Transgenic band: 250 bp 
Wt1 Initialization  
Denaturation  
Annealing  
Extension  
 
Final extension  
Final hold 
95°C….2 min 
95°C….30 s 
54°C….30 s 
72°C….2 min → go to 
step 2, repeat 34 times 
72°C….10 min 
15°C…. forever 
Wildtype band: 320 bp  
Transgenic band: 260 bp 
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6.2.3.4 Body and kidney weight analysis and urine collection 
Wt1 het del mice were weighed, and the urine was collected before sacrificing the mice. For the 
kidney to body weight ratio analysis, mice were sacrificed on postnatal day 6 and the kidneys 
were weighed accordingly. To minimize the technical errors during the experiment, the same 
balance was used throughout the study. 
6.2.3.5 Immunofluorescent staining on kidney tissue 
For the immunofluorescent (IF) staining of the kidney tissue, different methods were applied 
in different projects according to the protein of interest and its localization in one hand and 
how the technique of choice can address the underlying question on the other hand. 
To achieve higher resolution at the glomerular basement membrane (GBM) level, an optical 
clearing technique was employed prior to immunofluorescent staining for the Wt1 het del study. 
(Unnersjö-Jess et al., 2018) Perfused kidneys were fixed in 4% formalin at 4°C overnight and 
transferred to ice-cold PBS the next day. Kidney samples were shipped to Royal Institute of 
Technology in Sweden under 4°C condition. Dr. David Unnersjö Jess has done the IF staining 
of the kidney samples for the Wt1 het del project.  
In brief, fixed pieces of kidneys were incubated at 4°C in hydrogel solution (HS) 
overnight. Samples were immersed in clearing solution (CS) at 50°C for 6 h. Kidney pieces were 
cut into 0.3 mm-thick slices using a Vibratome. Slices were incubated at 50°C in CS overnight. 
Before immunolabeling, samples were washed in PBST for 10 min and incubated in primary 
antibody for 24 h at 37°C. Next day, samples were washed in PBST for 10 min at 37°C followed 
by secondary antibody incubation for 24 h at 37°C. For mounting, samples were immersed in 
80% (w/w) fructose with 0.5% (v/v) 1-Thioglycerol at 37°C for 1 h before imaging. Samples 
were mounted in a glass bottom dish and imaged using a Leica SP8 3X STED system. The 
antibodies used were as follows: β1-integrin, Nephrin, Collagen IV, Podocin, EphB1 and 
EphrinB1. PBST was used as diluent for all the steps.  
To address differential protein expression within glomerular cell types and overcome the 
inherent autofluorescence effect in the kidney tissue, a novel technique was adapted from IF 
staining of the spheroids in culture. (Giles et al., 2014) In brief, isolated mouse glomeruli from 
Nphs2Cre x mTmG mice in a CD1 background were seeded in Matrigel in 8-well µ-slides. After 
solidification, fixation was completed using 10% PFA for 30 min at room temperature (RT) and 
wells were gently washed with PBS containing Ca2+ and Mg2+. Samples were permeabilized 
with the permeabilization buffer for 30 minutes at RT and incubated with the primary antibody 
at 4°C overnight. After washing, the secondary antibody incubation was done for 4 h at RT. 
Samples were mounted with Vectashield and confocal stacks were acquired using a Leica SP8 
confocal microscope equipped with a 63x/1.4 oil immersion objective operated with the LAS 
X software version 3.1.5. Image acquisition settings were comparable among all images. The 
antibodies used were as follows: Cald1, Lars2 and their relevant isotype controls. 
Permeabilization buffer was used as diluent for all the steps.  
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6.2.3.6 Image analysis 
For the GBM thickness analysis, β1-integrin signal was used to assign the inner and outer 
boundaries of the GBM in ImageJ and the lines were imported into MATLAB and a custom-
written code was used to measure the GBM thickness in 100-nm intervals along the GBM and 
the GBM thickness was reported in microns by Dr. David Unnersjö Jess. The GBM thickness of 
relevant biological samples was plotted in GraphPad Prism 5. 
For EphrinB1 signal intensity quantification, regions of interest (ROI) and the slit diaphragm 
(SD) were manually assigned using the podocin signal in ImageJ. The mean intensity values 
and SD length were obtained from ROI manager command. The EphrinB1 mean intensity was 
normalized to that of podocin to correct for possible technical artefacts and the Spearmann 
correlation test was employed in R to plot the results. 
6.2.3.7 Periodic Acid–Schiff staining 
The kidneys were fixed in 4% formalin at 4°C overnight. The samples were soaked in cold PBS 
the next day and inserted in a tissue processor in the Center of Pathology, University Hospital 
Cologne. After complete dehydration, tissue was embedded in paraffin and sections of 4 μm 
were cut and air-dried overnight on glass slides. Afterwards, sections were rehydrated and 
soaked in 0.9% Periodic Acid for 10 minutes and rinsed with distilled water for 1 minute. Next, 
the slides were soaked in Schiff reagent for 10 minutes and rinsed with tap water for 2 minutes 
and incubated in Mayer’s Hematoxylin Solution. After washing for 8 minutes, the blue color 
was developed in the nuclei. Sections were dehydrated in increasing ethanol concentrations 
and mounted with Histomount. Images were obtained using Leica SCN400 Slide Scanner on a 
40x magnification. Glomeruli of the P6 mice were manually counted in ImageJ and the 
glomeruli counts were reported in mm2 cortex area. 
6.2.3.8 Colloidal Coomassie Blue staining 
Urine samples were cooked in a 1:10 ratio in a mix of 2xLäemmli buffer supplemented with 
Dithiothreitol and ddH2O for 5 minutes at 95°C. Samples were loaded on 10% Sodium Dodecyl 
Sulfate Polyacrylamide gel electrophoresis. SDS gels were incubated in 25ml fixation solution 
for 30 minutes at RT on a shaker. Gels were washed with slow-running tap water for a few 
seconds and incubated in 25 ml Colloidal Coomassie Brilliant Blue solution activated with 
methanol overnight at RT on a shaker. De-staining was carried out using distilled water at 
room temperature for 48 h. Images were acquired after complete de-staining with Odyssey 
CLx imaging device.  
6.2.3.9 Albumin to Creatinine Ratio (ACR) determination 
Urinary albumin concentration was measured with a commercially available ELISA kit 
according to the kit instruction. In brief, 100 µl of the standard or diluted urine samples 
(1:1000) were loaded in pre-coated wells and incubated for 30 minutes at RT. After washing, 
secondary antibody incubation was done for 30 minutes at RT. Chromogenic substrate was 
added in dark and the reaction was stopped by addition of stop solution after 10 minutes. The 
42 
 
absorbance was determined at 450 nm on a multimode plate reader. Analysis was performed 
according to the kit instructions. Using the standard sample reads, standard curve was 
obtained, and the test sample values were interpolated accordingly. The results were 
corrected for the dilution factor to acquire the original values. 
Urinary creatinine concentration was determined using a colorimetric assay. 15 μl of the 
standard or the diluted urine samples (1:20) were loaded per well. After addition of 150 μl 
alkaline picrate solution, the initial absorbance was measured at 490 nm. Final absorbance 
was determined after the addition of 5 µl acid solution at 490 nm. An equation was acquired 
using the linear regression of the standard curve. Creatinine levels per sample was calculated 
using the following equations: 
Corrected absorbance for each sample = average initial absorbance – average final absorbance  
𝐶𝑟𝑒𝑎𝑡𝑖𝑛𝑖𝑛𝑒 (
𝑚𝑔
𝑑𝑙
) = [𝑐𝑜𝑟𝑟𝑒𝑐𝑡𝑒𝑑 𝑠𝑎𝑚𝑝𝑙𝑒 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 − (
𝑌−𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡
𝑠𝑙𝑜𝑝𝑒
)]  𝑥 𝑠𝑎𝑚𝑝𝑙𝑒 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛  
6.2.3.10 Isolation of the glomeruli from mouse kidney 
Glomeruli were isolated from the mouse kidneys as described before. (Boerries et al., 2013) 
In brief, kidneys were dissected together with the abdominal aorta after cervical dislocation 
of the mouse and each kidney was perfused with 1-2 ml of magnetic beads solution consisting 
of Magnetic Dynabeads in 1x Hank’s Buffered Salt Solution (HBSS). Renal capsules were 
removed, and kidneys were minced in 1-mm3  pieces using a scalpel. Digestion was done in 3 
ml of the digestion solution in 37 °C for 15 minutes on a plate shaker. To facilitate digestion, 
kidney pieces were triturated using a cut pipettete filter tip. Digested kidneys were meshed 
twice through a 100-μm cell strainer and centrifuged. Glomeruli were collected after re-
suspending the pellet using DynaMag Magnet. 
6.2.3.11 RNA isolation 
Isolated glomeruli were homogenized in 700 µl TRI reagent and 140 µl chloroform was added 
to the homogenate. After centrifugation, the aqueous phase was collected, and total RNA was 
extracted using the miRNeasy RNA extraction kit. RNA quality was assessed on RNA screen 
tape and all the samples showing RNA integrity number (RIN)> 8 were submitted to the 
Cologne Center for Genomics (CCG, Cologne, Germany) for sequencing. Ribo-minus libraries 
were constructed according to the standardized protocols and paired-end sequencing was 
done on an Illumina HISeq sequencer. 
6.2.3.12 Wt1 chromatin immunoprecipitation 
Wt1 chromatin immunoprecipitation (ChIP) was performed by Dr. Maximillian Lenz in 
Nephrolab, University of Cologne. Mouse kidneys from 4-week old mice were processed by 
dissecting the cortex from medulla and mincing. Crosslinking was performed using 1% 
formaldehyde in PBS followed by quenching with 125 mM glycine. Further tissue disruption 
was carried out using a rotor-stator homogenizer in sterile 0.3 mM NaCl RIPA supplemented 
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with protease inhibitor. The pellet was sonicated in the sonication buffer on a probe-tip 
sonicator to achieve an average chromatin size ranging between 200-600 bp. Sonication 
efficiency was checked on a 2% agarose gel for each ChIP round. After sonication, sample was 
filled up to 1 ml with 0.3 RIPA, the Protease inhibitor was refreshed, and IP was carried out 
overnight by adding 3 μg of Wt1 C19 antibody or IgG isotype control. Samples were incubated 
with Protein G Dynabeads the next day for 2-3 hours at 4°C. After washing and elution, de-
cross linking was done in SDS elution buffer at 65°C overnight. DNA extraction was completed 
using phenol / chloroform/ isoamylalcohol 25:24:1. Following centrifugation, the aqueous 
phase containing the purified DNA is transferred to clean tubes and DNA is recovered by 
alcohol precipitation.  
6.2.3.13 Tead1 chromatin immunoprecipitation 
Mouse kidneys from 8 to 10-week old mice were used for isolation of glomeruli. Crosslinking 
was performed using 1% formaldehyde in PBS followed by quenching with 125 mM glycine. 
Sonication was completed in the ice-cold fresh nuclear lysis buffer (NLB) supplemented with 
protease inhibitors on a Covaris M220 Focused-ultrasonicator for 5 minutes. A total of 8 mice 
were used as input per immunoprecipitation round and the sonication efficiency was checked 
on a 2% agarose gel per round. Chromatin buffer was added to samples in a 2:3 ratio, protease 
inhibitor was refreshed, and IP was carried out at 4°C overnight by adding 6 μg of Tead1 
antibody or IgG isotype control priorly bound to Protein G Dynabeads. After washing and 
elution, de-cross linking was done in SDS elution buffer at 65°C overnight. DNA extraction was 
completed using phenol / chloroform/ isoamylalcohol 25:24:1. Following centrifugation, the 
aqueous phase containing the purified DNA is transferred to clean tubes and DNA is recovered 
by alcohol precipitation.  
6.2.3.14 Analysis of ChIP efficacy by qPCR 
Before proceeding to sequencing, qPCR was routinely employed for each ChIP round using 
equal amounts of 1% Input, IgG and IP DNA in Power SYBR Green PCR master mix reaction a 
fast real-time PCR system. Fold enrichment analysis of ChIP DNA compared to IgG control DNA 
was calculated as 2 ((Ct(IgG)-Ct(input))-(Ct(ChIP)-Ct(input))). All the primers used in qPCR experiments 
are enlisted in Table 6-3. To compare the fold enrichment between the positive and the 
negative loci, student’s t-test with Bonferroni’s correction was used. The 1% Input DNA and IP 
DNA samples passing the quality control check, were submitted to the Cologne Center for 
Genomics (CCG) for library preparation. Strand single-end library was constructed according 
to the standardized protocols and sequencing was performed using Illumina HISeq sequencer. 
6.2.3.15 Preparation of single cells from isolated mouse glomeruli 
For single cell preparation, isolated mouse glomeruli from 8-week old CD1 male mice were re-
suspended in 1 ml of tissue digestion solution and digestion was performed on a thermo-
shaker set to 37°C at 1400 rpm for the total of 40 minutes. Mechanical dissociation of the 
glomerular structure was facilitated by vortexing, trituration through a pipette and/or gentle 
shearing through a 27-gauge syringe on 5-minute intervals. Next, magnetic Dynabeads were 
44 
 
removed and the single cells were collected by centrifugation at 5000x g at 4°C for 10 minutes. 
Cells were re-suspended in ice-cold PBS and sieved through a 50-µm mesh. Cell sorting was 
carried out on a FACSAria III device gated for live single cells. 7-Aminoactinomycin D (7-AAD) 
was used to mark the dead cells. Cell fixation was done in ice-cold 80% methanol in PBS and 
shipped to the Max Delbrück Center for Molecular Medicine in Berlin for the preparation of 
monodisperse droplets for single cell RNA sequencing. 
6.2.3.16 Single-cell mRNA-sequencing 
Dr. Christine Kocks and Ms. Anastasia Boltengagen have performed the experiments regarding 
the drop-sequencing procedure, single-cell and bulk mRNA library preparation and 
sequencing according to an established protocol. (Macosko et al., 2015) In brief, 1-nanoliter 
monodisperse droplets were prepared on a drop-seq setup. During the formation of nanoliter 
droplets, single cells were encapsulated with individual, uniquely barcoded beads. Single cells 
were lysed and the polyadenylated RNA molecules were hybridized to the polyd(T) primers 
attached to the beads. Next, nanoliter droplets were collected and RNA molecules were 
captured, and paired end read library was prepared accordingly. Sequencing was performed 
after spiking 1% PhiX Control v3 Library on Illumina Nextseq 500 sequencer. For bulk mRNA 
sequencing, total RNA was extracted from isolated glomeruli or fixed single cells using TRI 
reagent. Single end read libraries were prepared and sequenced on Illumina Nextseq 500 
sequencer. 
 Bioinformatics analysis  
For the Wt1 het del and Tead1 projects, all the NGS analyses have been done by Tim Padvitski. 
If not stated otherwise, plotting and data analysis was performed in R software environment 
(version 3.4), plotting was done using ggplot() function. Dr. Nikos Karaiskos has carried out the 
single cell RNAseq analysis. 
6.2.4.1 Mapping and peak calling of ChIPseq data 
To map the ChIPseq reads on the mouse genome, mm10 was retrieved from UCSC genome 
browser. Mapped reads with MAPQ quality score< 30 and the duplicated reads were filtered 
out and the remaining reads were used to call peaks using MACS2 NarrowPeak algorithm with 
default parameters. 
6.2.4.2 Quality control 
Cross correlation analysis and IDR analysis were applied as the quality control step. Metagene 
plots of the nucleotide conservation and primary motif enrichment were generated for 
consensus Wt1ChIPseq and Tead1ChIPseq peaks in the respective samples. The nucleotide 
conservation around the peaks center was generated by bwtool using mm10 phastCons scores 
for multiple alignments of 59 vertebrate genomes to the mouse genome, retrieved from 
UCSCS. The primary Wt1 and Tead1 motif density around the peaks center was calculated with 
Homer software. 
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6.2.4.3 Differential binding analysis 
Differential binding analysis was performed using DiffBind R package. The location of peaks 
was extended up to 500 nucleotides in both directions and merged into one consensus peak. 
Consensus peakset was derived by selecting peaks occurring in both ChIPseq samples. The 
input control read counts were subtracted from each site per sample and the reads from the 
IP samples were counted into consensus peakset. Differential binding analysis compares 
number of reads between wildtype and Wt1 het del samples in each peak of the consensus 
peakset using DEseq2 algorithm.  
Target gene inference was completed using ClosestGene algorithm from TFTargetCaller R 
package. The algorithm identified 602 target genes (FDR 10%) of the consensus wildtype 
peakset. No statistically significant targets (FDR 10%) were found using Wt1 differentially 
bound sites and therefore all the assigned 602 genes were used in the downstream analysis. 
Genome browser plots of selected Wt1 target genes were generated using Gviz R packages.   
6.2.4.4 Peak annotation and region-gene association analysis 
Each peak in Wt1 and Tead1 consensus peak sets was annotated with nearest TSS and GO 
term using annotatePeaks.pl tool from homer v4.9.1 suite of tools, the same tool was used to 
calculate distances between closest WT1 and Tead1 peaks.  
6.2.4.5 Wt1-Tead1 co-binding analysis 
Wt1-Tead1 co-binding was defined as any instance of overlap between Tead1 and WT1 peaks 
and then co-bound regions were annotated as described above. 
6.2.4.6 Mapping and differential expression analysis of RNAseq data 
Raw RNAseq reads were mapped to GRCm38.p5 mouse genome assembly using STAR. 
Percentage of reads uniquely mapped to mouse genome for all 12 samples was in the range 
between 87%-89%. Distribution of mapped tags across different groups of features (exons, 
introns, UTRs, etc.) was estimated using GRCm38_GENCODE_VM11_comprehensive 
reference gene model downloaded from USCS. Genes with average expression across all 
samples below 1 were excluded from the analysis. The factors of unwanted variation (possible 
batch effects) were estimated by RUVr function of RUV-seq R package and differential 
expression analysis was performed by DEseq2. 
6.2.4.7 Hierarchical clustering and GO term functional annotation analysis 
GO enrichment analysis was performed with a custom function developed by the group of 
Professor Dr. Andreas Beyer (https://github.com/robertsehlke/SETHRO). For each gene list, 
gene ontology annotations of mouse genes were obtained from R package. Hierarchical 
clustering of gene expression logarithmic fold changes between wildtype and Wt1 het del mice 
was made using Manhattan distances and ward.D agglomeration method. GO enrichment of 
genes differentially expressed in early or late FSGS were tested against the whole gene 
universe. 1325 GO terms were significant after FDR correction (adjusted q value <0.1) in one 
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or both stages of FSGS. Next, mean logarithmic fold change (LFC) of all gene members was 
separately calculated for early and late FSGS for each of the 1325 GO terms. As a result, each 
term had 2 mean LFC values associated with it which correspond to the overall changes in 
early and late FSGS. Consequently, mean LFC at early FSGS was plotted against mean LFC at 
late FSGS for each GO term. 
6.2.4.8 SPIA pathway analysis 
Signaling Pathway Impact Analysis (SPIA) was done with Graphite v1.24.1 R package for KEGG 
and Reactome pathways. The algorithm combines 2 kinds of evidence: gene enrichment and 
strength of pathway perturbation in one summary statistics. Specifically, the probability of 
obtaining at least the observed number of genes on the given pathway just by chance (pNDE) 
is combined with the probability of obtaining the observed or more extreme total 
accumulation on the given pathway just by chance (pPERT). 
6.2.4.9 RNAseq and ChIPseq integration analysis 
For generation of LFC density and volcano plots, top 100 target genes of Wt1 differential 
binding were defined as genes with 100 highest scores from unfiltered TFTargetCaller results. 
Distribution of logarithmic fold changes (LFC) of the top 100 targets of Wt1 differential binding 
and all significant targets of wildtype Wt1 binding were plotted for both stages of FSGS. LFC 
distribution of all quantified genes was plotted as a background density.  
For the integrative GO plot, target genes of Wt1 differential binding were functionally 
annotated using the GO annotation function described above. Significant (q-value <0.1) 
annotations were then visualized using information of differential binding and differential 
expression. 
6.2.4.10 Single-cell and bulk mRNAseq mapping 
For the alignment of bulk mRNAseq, reads were mapped to the Mus musculus reference 
genome mm10. Gene expression quantification was done using the GENCODE M12 (Ensembl 
87) annotation. In brief, read 1 was defined as the first 20 base pairs spanning the cell barcodes 
from 1 to 12 bp and the UMI from 13 to 20 bp. The remaining 64-bp sequence was defined as 
read 2 leaving out the 8bp index reads. Sequencing quality was assessed by FastQC, the cell 
and molecular barcodes were added to the reads and barcodes with low quality bases were 
filtered out. The reads were then mapped to the reference genome and the multi-mapping 
reads were removed. Next, gene annotation tags were added to the reads using the Drop-seq 
toolkit 2. 
6.2.4.11 Clustering, t-SNE representation and marker discovery 
First, principal component analysis was performed using Seurat. The utmost principal 
components were used for clustering and tSNE representation. Next, the function 
“FindAllMarkers” in Seurat was employed to unbiasedly identify the markers per cluster.  
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6.2.4.12 Sub-clustering and gene ontology analysis 
To identify podocyte and endothelial cell sub-clusters, both cell types were extracted from the 
main cluster and treated independently. The resulting digital gene expression (DGE) matrices 
were sent to Seurat. For the podocyte sub-clusters, stress response genes were regressed out. 
To identify the functional annotations associated with podocytes and endothelial cell sub-
clusters, pathway and gene set overdispersion analysis (PAGODA) was employed. 
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7 Results 
7.1  Part one: Wt1 
 Haploinsufficiency of Wt1 triggers no defect in the kidney development. 
Mice carrying a neomycin selection cassette substituting the exon 1 + 0.5 kb of the Wt1 
sequence develops a gradual and yet slow podocyte damage marked by proteinuria and 
sclerotic lesions. (Kreidberg et al., 1993; Menke et al., 2003) These mice were crossed with the 
FVB/N breeder mice up to >20 generations to expedite the onset of the podocyte injury. 
(Figure 7.1-A) Wt1 het del mice were born healthy according to the mandolin ratios and the 
average litter size of 9.5 known from FVB/N inbred strain. (Taketo et al., 1991) The male Wt1 
het del mice were used as the experimental mice throughout all the procedures. The mice 
manifested no evident developmental phenotype in the kidneys when the urine samples from 
P6 mice were evaluated for proteinuria using the Coomassie staining. (Figure 7.1-B) Moreover, 
analysis of the urinary albumin/creatinine ratios (ACR) showed that albumin excretion was not 
significantly different between the Wt1 het del mice and the control littermates. (Figure 7.1-D) 
The kidneys displayed no size, weight, color or shape difference when comparing the Wt1 het 
del with the wildtype mice. (Figure 7.1-C) In line with this, the kidney/body weight ratios were 
not different between the Wt1 het del and the control mice. (Figure 7.1-E) To further investigate 
the impact of Wt1 haploinsufficiency in the kidney development, kidney histology was 
assessed using PAS staining. The general kidney structure as well as the glomerular 
architecture showed normal morphology at P6 in Wt1 het del mice and the wildtype controls. 
(Figure 7.1-F) Besides, no significant difference was found in the number of glomeruli between 
wildtype and Wt1 het del mice at P6. (Figure 7.1-G) Altogether, no defect was identified in the 
kidney development of Wt1 het del mice.  
This finding is particularly important due to several key aspects: Firstly, Wt1 is a master 
transcription factor with multiple functions in podocyte development, homeostasis and injury. 
(Hastie, 2017) Secondly, majority of the malignancies and syndromes associated with 
mutations in Wt1 compromise the role of Wt1 in development. These ailments are often 
represented by Glumerosclerosis besides urogenital defects and other disease phenotypes. 
(Baird et al., 1992; Klamt et al., 1998; Pelletier et al., 1991; Ruf et al., 2004) Thirdly, disrupted 
kidney development can involve initial podocyte deformity and dysfunction which can lead to 
Glumerosclerosis. However, the focus of this thesis is the concept of FSGS as a pathological 
pattern of either primary or secondary podocyte injury in which the podocyte homeostasis is 
perturbed. The aim is to mechanistically investigate into the pathways linked to FSGS 
pathology. Hence, the selected murine animal model should enable us to differentiate 
between an initial as opposed to a late phase of podocyte damage. The model of choice must 
represent a normal kidney development with no podocyte injury manifestation (e.g.: 
proteinuria, decreased glomerular count, aberrant glomerular histology, etc.). Yet, the 
podocytes should gradually start to show abnormal structural and functional features.  
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Figure 7.1: Heterozygous deletion of Wt1 does not impose any developmental defect in mouse 
kidneys.  
A- Schematic representation of the Wt1 het del mouse model. Wt1 Exon 1 and its 0.5 kb upstream is 
substituted with a neomycin cassette in one of the alleles. B- Coomassie staining for the urine 
samples of mice at postnatal day 6 (P6) shows no proteinuria in male mice under heterozygous 
deletion of Wt1. C- Images of the kidneys at P6 show no difference in size, color and morphology in 
mice between Wt1 het del mice and littermate controls. D-Quantification of urinary albumin at P6 
between Wt1 het del and the control mice. ns: not significant. E- Kidneys to body weight ratios (mg/mg) 
of mice at P6 show no significant difference between Wt1 het del and control mice. ns: not significant. 
F- PAS staining of the kidneys at P6 in both wildtype and Wt1 het del mice. At P6, the glomeruli are 
completely developed, and no abnormality is detectable. Scale bar: 20 µm. G- Analysis of the 
glomerular numbers in Wt1 het del vs. control mice at P6. Glomerular counts are not significantly 
different in the Wt1 het del and control mice 
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Majority of the existing FSGS mouse models show very severe and rapidly progressive 
phenotypes. Thus, they hardly allow for reasonable longitudinal investigation to differentiate 
between mechanisms relevant to early vs. late phase FSGS. (Fogo, 2003) To overcome this 
issue, Wt1 het del model was re-investigated as an FSGS mouse model which mimics a human 
mutation described as causative for SRNS/FSGS. (Menke et al., 2003; Schumacher et al., 2011) 
In this regard, the first step was to check the gradual appearance of FSGS phenotype. 
Therefore, the urinary and histological assessment of the Wt1 het del mice was performed at a 
rather young age (4-week-old mice) and in adulthood (12-week-old mice) and compared to 
the control littermates. 
 Heterozygous deletion of Wt1 leads to development of FSGS. 
As previously mentioned, Wt1 het del mice is reported to develop FSGS. (Menke et al., 2003) To 
confirm the contribution of Wt1 heterozygous deletion in the development of FSGS in the new 
background strain and to assess the onset of phenotypes, the urine samples were examined 
for albuminuria using Coomassie staining and ACR analysis. Wt1 het del mice developed a 
prominent and yet significant protein excretion at age 4 weeks. Albuminuria continued to exist 
as the mice aged. (Figure 7.2-A) ACR analysis showed significant elevation in albumin excretion 
in the Wt1 het del mice. (Figure 7.2-B) Assessment of the kidneys of Wt1 het del mice using PAS 
staining showed no evident sclerosis in mice at 4 weeks. However, the EM images of the 
kidney cortex displayed scarce ultrastructural changes at the slit diaphragm resolution. At age 
12 weeks, both PAS and EM images confirm evident sclerosis marked by extensive foot 
processes effacement and the thickening of glomerular basement membrane. (Figure 7.2-C) 
Altogether, these data showed that in the Wt1 het del mice, FSGS starts to develop as of around 
4 weeks with proteinuria and no explicit sclerosis (non-sclerotic FSGS) and continues to 
progress to a marked sclerosis associated with proteinuria at age 12 weeks (sclerotic FSGS). In 
other words, podocyte damage in 4-week Wt1 het del mice are in its early stage whereas 12-
week Wt1 het del mice manifests late stage of podocyte injury. Therefore, it is logical to expect 
differences in transcriptomic signature between early vs. late stage of podocyte damage. To 
investigate this, RNA sequencing analysis was performed in the next step. 
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Figure 7.2: Wt1 het del mice develops proteinuria and FSGS. 
 A- Coomassie staining for the urine samples from Wt1 het del mice at 4 and 12 weeks shows mild and 
severe proteinuria, respectively. B- Albumin/creatinine ratios (ACR) at week 4 and 12 are significantly 
elevated in Wt1 het del mice. Asterisk depicts p value is < 0.05. C- PAS staining of the kidneys at week 4 
and 15 in both wildtype and Wt1 het del mice. At week 4, there is no sign of sclerosis. At week 15, 
however, sclerotic lesions are apparent. Scale bar: 20 µm. Corresponding electron microscopy images 
of the kidney samples at 4 vs. 15 weeks in control vs. Wt1 het del mice. There are slight ultrastructure 
changes at 4 weeks whereas majority of the foot processes exhibit a normal structure. Extensive 
effacement of foot processes and the basement membrane thickening is evident at 15 weeks. BM: 
basement membrane, FP: foot processes, EC: endothelial cell. Scale bar: 500 nm 
 
 Distinct analysis modalities offer exquisite information by focusing on 
“Early FSGS”, “Late FSGS”, “FSGS progression” and “glomerular 
maturation and aging”.  
RNAseq analysis of isolated mouse glomeruli was performed in Wt1 het del mice at 4 (non-
sclerotic FSGS) and 12 weeks (sclerotic FSGS) and compared with wildtype controls. As the 
RNAseq dataset is comprised of four groups (Wt1 het del and wildtype, 4 weeks versus 12 
weeks), the comparison modality was schemed in the first step. Figure 7.3-A shows four 
modes of comparison in our experimental design and the relevant MA plots depicting the 
differential expression for each pairwise comparison are plotted in Figure 7.3-B. Comparison 
of Wt1 het del and control mice at 4 weeks and 12 weeks of age show the differential expression 
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of genes in early and late stage of FSGS, respectively. (termed as “Early FSGS” and “Late FSGS” 
hereafter). On the other hand, comparison of control mice at 4 weeks and 12 weeks of age 
denotes the differential expression of genes involved in “ 
glomerular maturation and ageing”. Similarly, comparison of Wt1 het del mice at 4 weeks and 
12 weeks of age denotes the differential expression of genes involved in “FSGS progression”. 
At the first glance, the “FSGS progression” represents highest number of differentially 
expressed genes (DEGs). However, “glomerular maturation and ageing” is an inherent 
phenomenon even in damaging podocytes and thus, the high number of DEGs in “FSGS 
progression” comparison is a result of “FSGS progression added by glomerular maturation and 
aging”. When “glomerular maturation and aging” is factored out, there are only very few DEGs 
contributing to “disease progression only”. (Figure 7.3-C)  
Conclusively, it is critical to mention that the comparison modality must give the most 
meaningful readout when collated with the bedside situation. In this regard, “glomerular 
maturation and aging” is not separate from “FSGS progression” in FSGS patients. Moreover, 
the aim in this thesis is to differentiate between the mechanisms involved in early vs. late 
podocyte damage. Therefore, the focus of the analysis is directed to comparing Wt1 het del and 
wildtype mice at 4 weeks (“Early FSGS”) and at 12 weeks (“Late FSGS”). Nonetheless, such 
datasets offer a versatile analysis potential which should not be taken for granted.  
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Figure 7.3: RNAseq analysis of the isolated mouse glomeruli from Wt1 het del and wildtype mice at age 
4 and 12 weeks.  
A- RNAseq analysis modality. Four comparisons are represented in the scheme: early non-sclerotic 
and late sclerotic FSGS (thick arrows) denote the comparison between wildtype and Wt1 het del at 4 
and 12 weeks, respectively; glomerular maturation and ageing and FSGS/disease progression (narrow 
arrows) denote the comparison between 4 and 12 weeks in wildtype and Wt1 het del, respectively. B- 
MA plot shows the relation between the mean of normalized counts (X axis) and the log2 FC (Y axis) 
of genes, computed for four selected comparisons explained in A. The red dots represent the 
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significantly DEGs (FDR adjusted p values < 0.05).C- MA plot shows the relation between the mean of 
normalized counts (X axis) and the log2 FC (Y axis) of genes, computed for “disease progression” 
when “aging” is factored out. The red dots represent the significant DEGs (FDR adjusted p values < 
0.05). 
 
  Haploinsufficiency of Wt1 leads to differential regulation of genes and 
or pathways in podocytes.  
PCA analysis of the dataset was performed as the first-step sanity check. The analysis revealed 
that the biological replicates cluster according to the age and genotype as the utmost sources 
of variation in this context. (Figure 7.4-A) Alignment of RNAseq data to the reference genome 
showed that between 30-40% of reads were mapped to the intronic regions and 25-30% to 
the coding exonic regions. (Figure 7.4-B, C) According to literature, the changes in the intronic 
read counts are not merely due to the technical artefacts. In fact, they directly reflect changes 
in transcriptional activity. (Gaidatzis et al., 2015) Hence, both exonic and intronic reads were 
utilized in downstream analysis to increase the statistical power of detecting direct 
transcriptional changes. Differential expression analysis of genes showed that although there 
is a remarkable overlap between the DEGs at early and late FSGS, majority of the DEGs are 
specific to either early or late FSGS. (Figure 7.4-D) Hence, it is highly likely that the mechanisms 
involved in podocyte damage are stage-specific. 
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Figure 7.4: Principal component analysis (PCA) and differential expression (DE) analysis of RNAseq 
data.  
A- The Principle Component Analysis (PCA) analysis of the RNAseq after application of removal of 
unwanted variation using residuals (RUVr). Principle component 1 (PC1) and 2 (PC2) represent age 
and genotype, respectively; percentages show the amount of variation explained by each principal 
component. Each dot represents one biological replicate. B- Venn diagram shows overlap of 
significant DEGs in exonic and intronic datasets. C- 2-D plot shows LFC values from DE analysis on 
exonic vs. intronic reads. The relationship between logarithmic fold changes in exonic and intronic 
datasets. Pearson’s correlation coefficient: 0.84, colored by adjusted p value. D- Venn diagram shows 
the intersect between genes significantly differentially expressed (FDR adjusted p values < 0.05) at 
early and late FSGS. Differential expression was computed using DEseq2. 
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Expectedly, GO term analysis showed the same trend, i.e.: there were some GO terms 
enriched either at early or at late FSGS and some others were enriched both at early and late 
FSGS. (Figure 7.5) The GO terms involved only in early FSGS probably reflect the events ensuing 
haploinsufficiency of Wt1 whereas the GO terms involved in late FSGS can reflect the 
inflammation and sclerosis during progressed podocyte damage. Similarly, the terms which 
are enriched both at early and late FSGS may denote the events generally happening during 
the podocyte damage. Expectedly, majority of the annotated GO terms were previously 
established as the key podocyte functions. There are solid pieces of evidence from literature 
suggesting the relevance of actin cytoskeleton homeostasis, cell adhesion, collagen biology, 
Ephrin signaling pathway, etc. in podocyte biology all of which have been found in our GO 
analysis. (Lennon et al., 2014; Sever and Schiffer, 2018; Weiss and Kispert, 2016) 
 
Figure 7.5: Functional annotation of DEGs at early and late FSGS. 
GO term plot depicting significant functional annotations of the DEGs in early and/or late FSGS. Each 
circle represents one GO term. X and Y axis represent mean log2FC of gene expression for the 
enriched GO terms in early and late FSGS, respectively. The blue line depicts the regression line and 
the red dash line defines the 95% prediction interval (PI). The terms located outside the PI have 
greater expression change of the contributing genes in early or in late FSGS. 
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One general limitation in the GO term analysis is that it is restricted to the DEGs and the 
network-based regulatory interactions are not considered. Hence, a network-based pathway 
analysis approach was employed to overcome this limitation. Signaling Pathway Impact 
Analysis (SPIA) is based on DEGs and the interaction between the genes in the relevant 
context. (Tarca et al., 2009)  
Essentially, SPIA uses two types of evidence to perform the pathway ranking:  
1- pNDE is defined as the probability of obtaining the observed number of genes (NDE) 
on the given pathway just by chance.  
2- pPERT corresponds to the probability of obtaining the observed perturbation on the 
given pathway just by chance. 
SPIA analysis offered a more in-detail and yet podocyte-specific insight on the pathways 
differentially regulated during the development of FSGS in the Wt1 het del mice. Again, some 
pathways were found to be perturbed only either at early or late FSGS and some other 
pathways were perturbed both at early and late FSGS. (Figure 7.6)  
Differential pathway regulation during the development of FSGS, fueled the speculation on 
Wt1 differential regulatory activity on the genome. Therefore, ChIPseq analysis of Wt1 was 
performed at non-sclerotic stage of FSGS (i.e.: at 4 weeks) to target potential transcriptional 
re-programming at the beginning of the disease. 
 
Figure 7.6: Results of the Signaling Pathway Impact Analysis (SPIA) of DEGs at early and late FSGS 
using KEGG and REACTOME databases.  
Global adjusted p-values (pGFDR) from SPIA statistics were log10 transformed and resulted values for 
inhibited pathways were multiplied by -1 to reflect “repression” as opposed to “activation” of the 
pathways. Some pathways are perturbed exclusively at early or late FSGS whereas some other 
pathways are perturbed both at early and late FSGS. 
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 Differential binding of Wt1 on the regulatory regions suggests 
transcriptional reprogramming at early disease stage. 
To further study if the differential gene and pathway regulation is a trail of an early re-
programming event under the Wt1 het del condition, Wt1 ChIPseq analysis was performed in 4-
week Wt1 het del and wildtype mice. Different ChIPseq quality metrics were employed to assess 
the quality of Wt1 ChIPseq dataset according to the ENCODE guidelines. (Landt et al., 2012)  
The consistency between the relevant biological replicates was evaluated using IDR analysis. 
(Figure 7.7-A) Majority of the signal from the samples was at the threshold =< 0.01 
substantiating the high quality of the Wt1ChIPseq dataset. To further assess the dataset 
quality, peak conservation score and de novo motif enrichment score were calculated for the 
merged peak summits and compared to the wildtype. (Figure 7.7-B, C) The quality of this 
dataset was approved again as the plots demonstrate sharp peaks at the center. Finally, the 
correlation heatmap of the ChIPseq normalized reads depicted that the samples are clustered 
according to the genotype. (Figure 7.7-D) Altogether, the quality of the ChIPseq dataset was 
high and the next analysis steps could be done on this dataset. 
Next, Wt1 peak distribution was assessed across the whole genome in Wt1 het del and wildtype 
samples. Majority of the peaks were concentrated remotely from the TSS. (Figure 7.7-E) This 
was in line with what was found previously on the binding affinity of Wt1 on different 
regulatory elements. (Kann et al., 2015) 
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Figure 7.7: Wt1ChIPseq at non-sclerotic stage of FSGS (4 weeks) compared to the wildtype mice.  
A- Irreproducibility Discovery Rate (IDR) analysis shows reproducibility of ChIPseq peaks of the 
relevant biological replicates for wildtype (upper panel) and Wt1 het del (lower panel). Each dot 
represents a peak: red dots correspond to genuine peaks at IDR <= 0.01. The axes show the log2 
transformed signals for each replicate. B, C- Metagene plots for consensus Wt1 ChIPseq peaks in 
wildtype (green) and Wt1 het del (magenta). The upper panel shows the nucleotide conservation 
around the peaks center where the nucleotide conservation is represented by mm10 phastCons 60-
way scores. The lower panel shows the primary motif density around the peaks center. D- Correlation 
heatmap of Wt1ChIPseq samples based on normalized read counts. It shows samples are clustered 
according to the genotype as the key source of variance. E- Density plot showing the distribution of 
distances between consensus Wt1ChIPseq and the nearest transcription start site for peaks in 
wildtype (green) or Wt1 het del (magenta). The density distribution is bimodal reflecting preferential 
binding at distant cis regulatory regions. 
 
Ultimately, differential binding analysis enabled identification of >600 regions significant at 
FDR< 0.05. Not surprisingly, majority of the differentially bound (DB) regions were less bound 
in Wt1 het del mice. (Figure 7.8-A) Taking a closer look at the certain target gene levels such as 
Actn1, Efnb1 and Col4a3 and 4 validated differential binding under het del condition. (Figure 
7.8-B) 
Taken together, these results show that haploinsufficiency of Wt1 primes re-programming 
events in earlier disease stages resulting in differential pathway regulation and the 
subsequent disease progression. 
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Figure 7.8: Differential binding analysis if Wt1-bound loci in Wt1 het del and control mice at 4 weeks. 
 A- MA plot showing the results of the differential binding (DB) analysis. Each point represents a 
binding site, with points in orange representing sites identified as differentially bound at FDR <5%. 
Majority of the DB regions are less bound under Wt1 het del condition. B- Genome browser plots for 
Wt1 target genes (Actn1, Efnbb1 and Col4a3/Col4a4) show decreased Wt1 ChIPseq signal 
(normalized to Input) in Wt1 het del mice (magenta) compared to wildtype (green). The DB track shows 
the location of the DB regions (orange). The annotation track shows the gene level annotation of 
mouse genome from Ensembl Release 96 (April 2019). 
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  Integrative analysis of binding and expression 
In order to pinpoint the key biological phenomenon underlying the development of FSGS in 
this study, the target genes of the Wt1 differential binding were predicted and the top 100 
genes were used to be assessed in terms of expression properties at early and late FSGS. For 
this purpose, log2 fold change of differential expression for these genes was plotted against 
the q value of their expression level. (Figure 7.9) 
 
Figure 7.9: Volcano plot representing the targets of Wt1 differential binding (orange) and Wt1 
binding in control condition (dark green) at early and late FSGS.  
Y axis shows the –log2qvalue of expression and is limited to 25 while the X axis shows the log2 fold 
change which is limited between -1 and 1. All points outside of the axis limits are plotted on borders.  
Expectedly, majority of DB genes have downregulated in late FSGS whereas in early FSGS, the 
total expression behavior of target genes has not markedly changed. Another representation 
of the volcano plots showed the same readout when plotting the log2FC of DEGs using the 
two aforementioned gene groups and all target genes as the background. (Figure 7.10)  
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Figure 7.10: LFC-density plot of differentially bound genes for early and late FSGS.  
LFC-density plots of top 100 DB (orange) and wildtype (green) Wt1 target genes at early (top panel) 
and late (bottom panel) FSGS. Both plots show that LFC distributions are different from that of the 
background for the aforementioned groups of target genes. The comparison of the plots for both 
groups of target genes highlights the shift in the LFC distribution between the early and late FSGS. 
 
The power of integrative computational analysis to infer the gene regulatory functions is way 
more robust than genome-wide profiling of TFs or gene expression alone. (Jiang and 
Mortazavi, 2018) Therefore, the next intriguing step was to functionally analyze the ChIPseq 
and RNAseq integration. For this purpose, target genes of Wt1 differential binding were 
functionally annotated and the significant annotations were derived using differential binding 
and differential expression of the target genes. The results of functional analysis were 
stimulating since “Collagne Binding” and “Ephrin Signaling” were enriched. (Figure 7.11) These 
functions were already found in the GO term enrichment analysis as well as pathway 
enrichment analysis of the RNAseq data. Therefore, they were further investigated in the 
context of FSGS using immunofluorescent imaging.  
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Figure 7.11: Integration of RNAseq and ChIPseq highlights key GO annotations contributing to the 
early and late FSGS.  
ChIPseq-RNAseq integration plot showing the LFC of binding and expression at early and late FSGS (X 
axis) for GO terms enriched in the DB genes. The color intensity of circle is proportional to the 
significance of GO term (-log2 of q-value) in the respective dataset. The size of circle is proportional 
to the size of the term (number of annotated genes). The GO terms are grouped by three categories: 
biological processes (BP), cellular components (CC) and molecular functions (MF). Selected terms are 
shown. 
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  Collagen biology is disturbed as FSGS develops. 
The glomerular basement membrane is a dense network composed of collagens, laminins, 
proteases, growth factors, heparan sulfate proteoglycans and other structural proteins. 
(Lennon et al., 2014) Among all the GBM constituents, collagens play a key role in providing a 
foundation for other structural molecules. In Wt1 het del and control mice, 22 subtypes out of 
28 known collagens are expressed at 4 and 12 weeks. (Figure 7.12) 
 
Figure 7.12: Heatmap depicts the expression values of collagen subtypes in Wt1 het del and control 
mice at 4 and 12 weeks.  
Only genes with a certain average expression across all replicates (> 0.5 Transcripts Per Million; 
TPM) are shown. This criterion does not exclude any significantly DE genes. 
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Genes contributing to collagen-related GO terms included the core components of the GBM 
and exhibited a significant differential expression in the course of FSGS (both at 4 and 12 
weeks). (Figure 7.13) 
 
Figure 7.13: Chord plot for Collagen Biology. 
Represented GO terms are relevant to collagen biology and their contributing DEGs at 4 and 12 
weeks are shown. Only log2 transformed fold changes of the DEGS significant for both ages are 
depicted.  
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Figure 7.14: Immunofluorescence staining of GBM components and evaluation of GBM thickness.  
A-Immunofluorescent staining for collagen IV, β1-integrin and nephrin in Wt1 het del and wildtype mice 
at weeks 4 and 12. STED images reflect the comparison between the wildtype and Wt1 het del mice at 
early and late FSGS. Appearance of hummocks along the glomerular basement membrane (GBM) as 
well as GBM thickening is visible less at early and more at late FSGS. (yellow arrows) The GBM 
expansion is increasing as the disease progresses (late FSGS). Scale bar: 2 µm. Image adapted and 
modified from (Jess, 2019) B- Quantification of the GBM thickness using the β1-integrin signal from 
the podocyte and the endothelial cell shows a marked increase in GBM thickness at early and late 
FSGS. The plot depicts median ± 95% of the confidence interval (CI).  
In line with the transcriptomic analysis, immunofluorescence staining of nephrin, β1-integrin 
and collagen IV is suggestive of distorted GBM components especially Collagen IV. STED 
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images showed appearance of hummocks along the slit diaphragm in Wt1 het del mice both at 
non-sclerotic and sclerotic stage of FSGS. (Figure 7.14-A) This phenomenon is accompanied by 
the contorted expression of the collagen IV subtypes in the areas where the GBM is visibly 
thickened. Using β1-integrin signal from the podocytes and endothelial cells, the GBM 
thickness was quantified at 4 and 12 weeks in Wt1 het del and wildtype mice. A marked increase 
in the GBM thickness is evident in the Wt1 het del mice during the progression of FSGS. (Figure 
7.14-B) 
 Ephrin signaling pathway is progressively impaired in the course of FSGS. 
Eph-Ephrin signaling is the largest kinase pathway which is under-investigated in the context 
of podocyte biology. The signaling cascade is routinely initiated upon receptor-ligand binding. 
(Lisabeth et al., 2013) Go term analysis of our RNAseq data showed that majority of the 
contributing genes to the “Ephrin signaling” GO term have undergone significant up/down 
regulation. (Figure 7.15-A) In a separate study, our single cell RNA sequencing revealed 
EphrinB1 and its receptor EphB1 have the highest expression among all other Ephrins and 
Ephs, respectively. (Figure 7.15-B) (Karaiskos et al., 2018) 
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Figure 7.15: DEGs contributing to Ephrin Signaling and podocyte-specific expression values of the 
Ephs and Ephrins.  
A- Chord plot for ephrin signaling. Represented GO terms are relevant to ephrin signaling and their 
contributing DEGs at 4 and 12 weeks are shown. Only log2 transformed fold changes of the DEGS 
significant for both ages are depicted. B- Density plot represents the expression values of Eph 
receptors and Ephrin ligands in the podocytes of CD1 male mice. The Y axis shows the expression 
values shown by adjusted UMIs (unique molecule identifiers). Data adopted from (Karaiskos et al., 
2018) 
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EphrinB1 is located at the slit diaphragm and it contributes to actin cytoskeleton remodeling 
via triggering an intracellular phosphorylation cascade which leads to increased podocyte 
motility and detachment. (Hashimoto et al., 2007) In Wt1 het del mice, the non-sclerotic FSGS 
(4 weeks) reflects only minor alterations in the glomerular architecture. Hence, any change at 
the protein level can be detected at progressed disease stage i.e. in late FSGS (12 weeks). 
Using a targeted mass spectrometry approach, EphrinB1 reduction was approved at 12 weeks. 
(Figure 7.16-A) However, this reduction was not significant which, per se, substantiated our 
speculation on the dependence of the EphrinB1 reduction to the extent of sclerosis at certain 
loci of the kidney. Therefore, EphrinB1 and EphB1 proteins were stained in 12-week mice using 
the optical clearing technique and images were taken across the kidney sections in order to 
have an overview on more damaged glomeruli. Not surprisingly, both EphrinB1 and EphB1 
showed a strong decrease in sclerotic areas in 12-week Wt1 het del mice when compared to 
controls. (Figure 7.16-B) 
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Figure 7.16: Assessment of EphrinB1 and EphB1 protein expression in late FSGS.  
A- Targeted proteomics on the isolated glomeruli of Wt1 het del and wildtype mice at 12 weeks. Wt1, 
NPHS1, NPHS2 are also included for normalization. EphrinB1 protein level is decreased when the 
sclerosis is explicit at 12 weeks when its abundance is normalized to the housekeeping and tubular 
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proteins. B- Immunofluorescent staining for nephrin (magenta), EphB1 (yellow) and EphrinB1 (blue) 
in Wt1 het del and wildtype mice at 12 weeks. The two upper panels depict the capillary side view 
(scale bar: 3 µm) whereas the lower two panels depict the glomerular overview (scale bar: 15 µm). 
Marked reduction of nephrin, EphB1 and EphrinB1 is visible in glomeruli affected by FSGS. EphB1 and 
EphrinB1 signals show a dotted pattern covering the capillary area. In Wt1 het del mice, loss of nephrin 
signal is evident at sclerotic loci. EphB1 and EphrinB1 co-disappear with the nephrin signal. 
 
Since EphrinB1 showed the highest expression level among the Eph receptors and the Ephrin 
ligands, it was tempting to perform EphrinB1 staining and quantify its intensity according to 
the disease progression. EphrinB1 was stained in 12-week mice together with podocin using 
the same staining technique. (Figure 7.17-A) In Wt1 het del mice, EphrinB1 mean intensity 
showed a significant reduction when it was normalized to podocin signal within the capillary 
area. (Figure 7.17-B) 
Our colleagues have recently found that the slit diaphragm (SD) length decreases significantly 
in sclerotic glomeruli in the course of FSGS. (unpublished data) Acknowledging this, SD 
Length/Capillary Area was employed as a measure of disease progression. In line with what 
our colleagues have shown, a marked decrease in SD Length/Capillary Area was measured in 
sclerotic mice (progressed disease). (Figure 7.17-C) To answer if the EphrinB1 intensity 
reduction is dependent on the extent to which the disease has progressed, the correlation 
between the SD Length/Capillary Area (disease progression) and the EphrinB1 mean intensity 
normalized to podocin mean intensity was assessed. A strong correlation was detected using 
the Spearmann correlation test (correlation coefficient = 0.81). (Figure 7.17-D) Conclusively, 
this correlation suggests that EphrinB1 expression is adversely affected by the disease 
magnitude.  
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Figure 7.17: EphrinB1 progressively reduces in the course of FSGS.  
A- Immunofluorescent staining for podocin and EphrinB1 in Wt1 het del and wildtype mice at 12 weeks. 
Images show the en face view of adjacent podocyte foot processes. In wildtype mice, podocin signal 
(magenta) shows the interdigitated foot processes with a normal structure. EphrinB1 signal (green) 
shows a dotted pattern covering the podocin-positive area. In Wt1 het del mice, however, loss of 
podocin signal is evident at sclerotic loci at 12 weeks (yellow arrows). EphrinB1 co-disappears with 
the podocin signal. Scale bar: 3 µm. B- Dot plot shows a significant reduction in EphrinB1 mean 
intensity as normalized to podocin signal intensity in Wt1 het del mice. (p value: 0.0011) C- Dot plot 
shows the SD length/Area in Wt1 het del and control mice at 12 weeks. SD length/Area is used as a 
measure of disease progression. SD length/Area is significantly less in progressed disease (12-week 
het del mice) when compared to the control mice. (p value: 0.0026) D- Evaluation of correlation 
between EphrinB1/Podocin signal and the disease progression. Disease progression is measured by 
SD length/ Area. Spearman correlation test suggests a strong correlation between disease 
progression and the EphrinB1/Podocin signal (p value: 7.7E-05). Each dot represents the SD length 
per area and the contributing EphrinB1/Podocin mean intensity ratio within the area. The red line 
represents the correlation coefficient (0.81).  
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7.2 Part two: Tead1 
 In wildtype mouse glomeruli, Tead1 is the effector of Hippo signaling 
pathway. 
The TEA domain (TEAD) transcription factors have four highly conserved subtypes in mammals 
with different levels of tissue expression. (Gibault et al., 2018) Our single cell RNAseq data 
revealed that Tead1 and 2, respectively, are the most and the least abundant transcription 
factors of the TEAD family in podocytes. (Figure 7.18-A) (Karaiskos et al., 2018) Using mass 
spectrophotometry, our colleagues have found Tead1 is significantly higher in podocytes as 
compared to non-podocyte cells in the kidney. (Figure 7.18-C) In line with this, 
Immunofluorescence staining of kidney sections validated this finding as Tead1 co-localized 
with Wt1 in the podocyte nucleus. (Figure 7.18-B) 
Taken together, Tead1 is the predominant Hippo effector in wildtype mouse glomeruli. 
Therefore, an in-depth molecular understanding of Tead1 function in podocytes depends 
highly on exploring the transcriptional network governed by this protein. 
 
Figure 7.18: RNA and protein expression of TEAD family members in podocytes. 
A- mRNA expression values of TEAD family TFs derived from glomerular single cell RNAseq dataset. 
(Karaiskos et al., 2018). B- Immunofluorescence staining of wildtype mouse glomeruli shows that 
Tead1 co-localizes with Wt1 in the nucleus. Green and magenta show Tead1 and Wt1 signals, 
respectively. Scale bar: 20 µm. Dr. Fabian Braun has performed the IF staining. C- FACS-sorted 
podocytes and non-podocyte cells derived from Nphs2Cre x mTmG mice shows differing protein 
abundance for Tead1 and 4 as evaluated by LFQ intensity values. Tead1 is significantly higher in 
podocytes compared to non-podocyte cells. Dr. Markus Rinschen has kindly shared the results from 
an unpublished dataset. 
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 Chromatin immunoprecipitation of Tead1 in isolated mouse glomeruli 
introduced technical hurdles.  
There are handfuls of challenges in obtaining antibodies for an efficient ChIP experiment. 
These challenges are more critical in the context of ChIPing for endogenous proteins in model 
organisms such as mice because the starting material for the immunoprecipitation is limited. 
A highly recommended alternative in such cases is to tag the protein of interest with an 
exogenous epitope and use an already-validated antibody against the exogenous tag. (Landt 
et al., 2012) Epitope-tagging solves the issue of batch to batch variation for antibodies. 
Moreover, using a well-characterized monoclonal antibody against the exogenous tag 
eliminates the possibility of epitopes cross-reaction. Given this, a novel mouse line bearing an 
exogenous Flag tagged to Tead1 was generated in this project using CRISPR/Cas9 technology.  
In order to efficiently design the recombinant Flag-tag Tead1, the first criterion to consider 
was to target the fusion peptide for a locus remote from the nuclear localization signal (NLS) 
sequence. All the TEAD family members have a classical bipartite NLS consensus sequence 
which is highly conserved. (Magico and Bell, 2011) In Tead1, the NLS consensus sequence is 
located at the residues 30 to 97. Moreover, the transcriptional activating domain is located at 
the residues 167 to 426 in the C-terminus of Tead1. Therefore, the best strategy was targeting 
the Flag-tag in exon 2 where it does not interfere with any of the mentioned domains. Another 
criterion was utilization of the endogenous start codon to avoid non-desired Flag expression 
without Tead1 protein. Furthermore, a flexible spacer (GGGGS) was included to avoid protein 
misfolding and compromised Tead1 function. (Chen et al., 2013) After the precise evaluation 
of several in-Silico designed sgRNA oligos, the best-matching one was selected for in vitro 
synthesis of the sgRNA. (Figure 7.19)  
 
Figure 7.19: Recombination target locus in the exon 2 of the mouse Tead1. 
The first two strands are the sense and non-sense nucleotide sequence of the target locus. The third 
sequence depicts the designed ssODN. The sgRNA targets Cas9 to cut after the start codon. The Flag 
and spacer sequences will be recombined after the first residue (Methionine). The amino acid 
sequence of the recombined locus is depicted as well.  
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T7 endonuclease I assay was used as the primary evaluation for successful sgRNA/Cas9 
mediated targeting. (Wyvekens et al., 2015) The heteroduplex DNA which was produced 
during the hybridization reaction was identified and cleaved by T7 endonuclease I. As a result, 
two DNA fragments with different band sizes (DNA modified after Cas9-mediated cut and non-
modified DNA) appeared in the agarose gel electrophoresis showing that Cas9 has cut the 
desired loci guided by sgRNA. (Figure 7.20) 
 
Figure 7.20: T7 endonuclease assay shows successful recombination of the sequence of interest.  
The genomic DNA is extracted from transfected NSC-34 cells after recombination. After cleavage by 
T7 endonuclease I, the recombined DNA is cut to a small and a big fragment shown on 2% agarose 
gel. The non-recombined DNA will not be cleaved by T7 endonuclease I.  
 
After this step, the electroporation of the zygotes with CRISPR/Cas9 components was 
performed as previously described. F0 generation mice included 9 live pups and sequencing 
results showed one mouse has the desired sequence. (Figure 7.21) The male founder was 
backcrossed to the inbred control females (C57BL/6) to obtain experimental mice after F10 
according to the guidelines provided by the LANUV NRW.  
 
Figure 7.21: Alignment of the sequence reads from the founder FLAG-Tead1 mouse with the 
designed recombinant Tead1.  
The upper panel depicts the recombined sequence using Benchling. The colored bars depict sgRNA, 
short and long homology arms and the flag and spacer sequences. The annotated sequence validates 
the successful recombination of Flag tag in Tead1 exon 2 with no off-target events within this 
window.  
 
Although exogenous tagging serves as a robust technique for ChIP experiments, it often raises 
doubts on the changes that it might introduce to the factor’s activity. ENCODE guidelines 
recommend employing a parallel endogenous protein IP in ChIP experiments in such cases. 
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(Landt et al., 2012) Besides, the time period for obtaining the experimental mice to perform 
ChIP experiments is often lengthy. To this end, a modified immunoprecipitation strategy was 
tested in parallel to mouse breeding to expedite the progress of ChIP experiments.  
Standard ChIP experiments are often performed using protein G magnetic beads. However, 
some mouse antibody isotypes do not efficiently bind to protein G magnetic beads. The Tead1 
antibody used in this project was validated for ChIP in several publications previously. (Stein 
et al., 2015; Tome-Garcia et al., 2018) However, all the Tead1 ChIP experiments have been 
performed in cells where the starting material is not a limit. After several attempts in 
performing Tead1 ChIP in isolated mouse glomeruli, the enrichment of the Tead1 target loci 
was not satisfactory. Therefore, addition of the pre-bound antibody-protein G complex to the 
nuclear lysate was employed as an alternative strategy to traditional immunoprecipitation 
assays and a commercially available bridging antibody was included prior to the addition of 
Tead1 antibody to the protein G magnetic beads. Bridging antibody is essentially a rabbit anti-
mouse IgG antibody which binds to both protein G magnetic beads and the mouse-driven 
antibody with a strong affinity. Therefore, it boosts the enrichment of protein-chromatin 
complex in ChIP experiments. The performance of bridging antibody in successful Tead1 
ChIPing was evaluated in IMCD3 nuclear lysates using mass spectrophotometry. A 250-fold 
enrichment of Tead1 was observed when bridging antibody was included in the 
immunoprecipitation procedure. (Figure 7.22-A) The result of ChIP-MS was encouraging to 
perform the Tead1 ChIP in nuclear lysates obtained from isolated mouse glomeruli. Successful 
Tead1ChIP in four replicates was assessed by qPCR and as expected, target gene loci (Lats2) 
was enriched significantly higher when the bridging antibody was included in the ChIP 
procedure. (Figure 7.22-B) Therefore the IP and input samples were submitted for sequencing.  
 
Figure 7.22: Addition of the bridging antibody significantly increases the Tead1 chromatin 
immunoprecipitation.  
A- Tead1ChIP-MS of the cross-linked IMCD3 nuclear lysates with and without the bridging antibody. 
The x-axis shows the ranking of the proteins from the most abundant to the least abundant. The y-
axis shows the relative protein abundance (iBAQ- log10 scale). There is a 250-fold enrichment of 
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Tead1 when the IP is performed with the bridging antibody. B- Tead1ChIP-qPCR of the cross-linked 
nuclear lysates taken from the mouse isolated glomeruli with and without the bridging antibody. 
There is a significant relative fold enrichment of the Tead1 target gene loci, Lats2, compared to the 
negative control loci, GAPDH, when the bridging antibody is used in the IP experiment. (p value < 
0.0001) 
 
 Quality check for Tead1 ChIPseq verifies robustness of the dataset. 
To assess the quality of Tead1 ChIPseq dataset, strand cross-correlation analysis was 
performed which showed a high signal-to-noise ratio. (Figure 7.23-A) As the next step of 
quality check, pairwise comparison of Tead1 ChIPseq peaks was done by the IDR method. 
(Figure 7.23-B) 
 
Figure 7.23: Three replicates of Tead1ChIP-seq show decent quality. 
 A- Strand cross-correlation analysis suggests the second and the third replicates have higher quality 
when compared to the first replicate. B- The IDR analysis shows that majority of the signal pass the 
threshold at 0.05. 
 
The consistency between the sample pairs was approved as majority of the signal passed the 
IDR threshold set at 0.05. Furthermore, peak conservation and de novo motif enrichment 
scores were calculated for the merged peak summits demonstrating very sharp peaks at the 
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center. (Figure 7.24-A, B) Expectedly, the known Tead1 motif had the highest enrichment 
score besides Wt1, Klf, etc. Finally, the spearman correlation test for the ChIPseq normalized 
reads depicted robust correlation coefficients for each sample and its relevant pseudo pair. 
(Figure 7.24-D) 
 
Figure 7.24: Tead1ChIPseq quality evaluation. 
A- Metagene plot of consensus Tead1 peaks shows high peak conservation. The x and y-axis 
depict the distance from the peak center and the average conservation score, respectively. B- 
Motif density plot of primary motif in Tead1 consensus peaks. High enrichment of Tead1 
primary motif shows successful ChIP experiment. The x and y-axis depict the distance from 
the peak center and the peak density, respectively. C- Sequence logos of the top 5 enriched 
TF motifs from de novo motif enrichment analysis of Tead1 ChIPseq. D- Spearman correlation 
test for the normalized reads shows high correlation coefficients per sample. 
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  In podocytes, Tead1 predominantly regulates genes involved in cell-
adhesion and actin cytoskeleton regulatory pathways. 
Tead1 peak distribution assessment across the whole genome revealed that most of the peaks 
were located far from the TSS. (Figure 7.25-A) In fact, majority of Tead1 peaks were in intronic 
and intergenic elements suggesting an enhancer-based transcriptional regulation. This is in 
line with existing literature on the enhancer-mediated transcriptional activity of TEAD family 
members. (Stein et al., 2015)  
Previously, TEA family members have been identified to mediate handfuls of cellular functions 
majority of which dealing with cell-substrate adhesion, cell migration, EGFR signaling and 
mechano-sensation via actin cytoskeleton homeostasis. (Tome-Garcia et al., 2018; Totaro et 
al., 2018, 2019) However, a great deal of literature in this area has focused on cancer cells. In 
this thesis, functional annotation analysis identified Tead1-dependent functions in podocytes. 
In wildtype healthy podocytes, Tead1 predominantly orchestrates gene-regulatory functions 
in cell-adhesion and actin cytoskeleton pathways. (Figure 7.25-B) Based on what was observed 
in Tead1 binding on the gene regulatory elements, it is not far from expectation that Tead1 
exerts its cellular functions by binding to intergenic and intronic sites in putative enhancers. 
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Figure 7.25: Enhancer-based regulation of actin cytoskeleton and cell adhesion in podocytes by 
Tead1.  
A- Pie chart shows the Tead1 peak distribution across genome features (promoters, intergenic 
regions, intronic regions, other regions). Majority of Tead1 peaks are located in intronic and 
intergenic regions suggesting enhancer-based gene regulation by Tead1. B- GO enrichment analysis 
shows majority of the Tead1 functions involve actin cytoskeleton homeostasis and cell adhesion. The 
x-axis shows the binominal fold enrichment of the GO terms whereas the y-axis shows the -log10 
transformed of adjusted p values. The GO annotations are subdivided into BP: Biological Processes, 
MF: Molecular Functions, CC: Cellular Components using three different colors. The size of the circles 
correlates with the number of the genes involved in the GO term.  
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 Cooperation of Tead1 and Wt1 in gene regulation by co-binding at key 
podocyte target genes.  
Our group has previously shown the co-occurrence of Wt1 and Tead1 motifs in Wt1 ChIPseq 
dataset obtained from adult mice. (Kann et al., 2015) In line with this, motif enrichment 
analysis of the Tead1 ChIPseq data showed mutual existence of Wt1 and Tead1 motifs, as well 
as Tcf21, KLF TFs, MafB, Lmx1B and CTCF motifs, suggesting these TFs tend to cooperate in 
their gene regulatory programs. (Figure 7.26-A) Acknowledging this, the distance distribution 
of the Tead1 and Wt1 ChIPseq adjacent peaks revealed majority of them happen to be remote 
from the TSS (more than 200 bp distance). Within this window, over 7000 mutual binding loci 
were identified for Tead1 and Wt1. (Figure 7.26-C) 
 
Figure 7.26: Tead1 and Wt1 co-binding assessment.  
A- Motif density plots within Tead1 & Wt1 co-bound peaks show motifs enriched in Tead1-Wt1-
bound regions. The x and y-axis depict the distance from the peak center and the density, 
respectively. B- Distance distribution density plot for adjacent Tead1 and Wt1 peaks. The y-axis 
shows the density while the x-axis depicts the log2 transformed of the absolute genomic distance in 
base pair. 27.26 = 153 bp. C- Pie chart shows the number of co-bound regions by Wt1 and Tead1 
divided into >200 pb and <200 bp distance.  
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In addition, Genome browser plots of exemplary target genes such as NPHS1 and 2, Itgα3 and 
Actn4 confirmed the co-occurrence of Tead1 and Wt1 binding sites which further provided 
strong evidence for interaction of the TFs on a gene-regulatory level. (Figure 7.27) 
 
Figure 7.27: Genome browser plots showing Tead1 and Wt1 ChIPseq signals and exon/intron 
structure of target genes. 
 The upper (blue) track shows Wt1 ChIPseq signal while the lower (red) track shows Tead1 ChIPseq 
signal. Promoters, intronic and intergenic sites show co-occurrence of Tead1 & Wt1 ChIPseq signals. 
The exon and introns are marked by the bottom blue boxes and lines, respectively. 
 
Functional annotation of the Tead1-Wt1 co-bound genes, moreover, re-approved Tead1 and 
Wt1-guided regulation of actin cytoskeleton homeostasis. (Figure 7.28) Interestingly, Wt1 
target genes seem to be regulated more independently whereas Tead1 target genes show 
more co-dependence to both transcription factors. Altogether, the results of this part 
demonstrate that Tead1 and Wt1 interact on a gene-regulatory level by co-binding at key 
podocyte target genes. Functionally, genes involved in actin cytoskeleton regulation and 
cellular movement are overrepresented among the targets of this interaction.  
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Figure 7.28: Functional annotation analysis of Tead1 and Wt1 co-binding on gene regulatory regions.  
Bubble plot shows the log transformed significance of GO terms overrepresented in the target genes 
of Tead1 & Wt1 co-bound peaks vs. Wt1 targets (y-axis), and vs. Tead1 targets (x-axis), respectively. 
Selected GO-terms are highlighted in bold. BP: biological process, CC: cellular component, MF: 
molecular function, and marked by three different colors. The size of the circles correlates with the 
number of the genes contributing to the GO term.  
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7.3  Part three: Single-cell RNA sequencing of isolated mouse 
glomeruli  
 Single-cell RNA-sequencing identifies the relevant cell populations in 
purified glomeruli 
Isolation of mouse glomeruli was performed using a standardized protocol. (Boerries et al., 
2013) The yield and quality of the glomerular isolation was checked, and extra washing steps 
was carried out if non-glomerular structures were abundant in each sample. (Figure 7.29-A) 
Live fixed cells were further processed for single-cell RNA sequencing using the Drop-seq 
method. (Macosko et al., 2015) Each independent biological replicate consisted of the single 
cells derived from isolated mouse glomeruli from 8 mice. Using unique molecular identifiers 
(UMIs), a total of 14,722 cells were identified. The general study design is schematically shown 
in Figure 7.29-B.  
 
Figure 7.29: Single-cell RNA sequencing of isolated mouse glomeruli.  
A- Brightfield microscopic images of isolated mouse glomeruli exhibiting high purity of glomerular 
isolation. Insets indicate a tubular fragment (left), a decapsulated glomerulus with protruding 
vasculature (middle) and an avascular, decapsulated glomerulus (right). Scale bar: 100 µm. B- 
Schematic design showing the experimental workflow. Image adapted from (Karaiskos et al., 2018) 
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Employing a previously developed algorithm, cell-type marker genes were scored, and 1768 
possible cell doublets were removed from further analysis. The number of cell doublets were 
normal given the fact that in Drop-seq experiments approximately 10% of identified cells are 
not singlet cells and this is an inherent phenomenon in the Drop-seq workflow. (Karaiskos et 
al., 2017) After the doublet removal, the data set consisted of 12,954 cells, with a median of 
630 genes and 950 unique molecular identifiers per cell. (Figure 7.30-A)  
Unsupervised clustering of the final single cells revealed five major cell clusters three of which 
were glomerular cell types: podocytes (80% of total singlet cells), endothelial cells (12%) and 
mesangial cells (2%). The other two cell types were tubular cells (6%) and immune cells (0.2%). 
(Figure 7.30-B) The results of the single-cell sequencing is offered on an interactive free 
webtool: https://shiny.mdc-berlin.de/mgsca/  
All the biological replicates were shown to contribute equally to the identified cell types (data 
not shown here). Identification of the cell types were based on the expression of the cell-type 
specific marker genes. Therefore, and as expected, glomerular cells showed specific 
expression of their established marker genes such as NPHS1 and 2 for podocytes, Pecam and 
Flt1 for endothelial cells and Ren1 and Acta2 for mesangial cells. (Figure 7.30-C) 
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Figure 7.30: Single-cell RNA-sequencing of the purified mouse glomeruli identifies five known cell 
populations.  
A- Median number of genes, transcripts (UMIs) and reads per cell in distinct replicates. The table 
enlists the number of cells and their relevant UMIs as well as the number of detected genes and 
transcripts per cell. Numbers are shown for data before and after doublet removal. B- tSNE plots (t-
Distributed Stochastic Neighbor Embedding) show five distinct clusters corresponding to glomeruli 
(12% endothelium [n=1556], 2% mesangial cells [n=216], and 80% podocytes [n=10,325]) and non-
glomerular structures (6% tubules [n=828] and 0.2% immune cells [n=29]) based on the top most 
variable marker genes per cluster. C- tSNE plots representing the expression of established marker 
genes colored based on the normalized expression levels (gray represents low and red represents 
high expression values). Image adapted from (Karaiskos et al., 2018) 
 
One general consideration in single cell RNA sequencing data interpretation is to compare the 
data to bulk mRNAseq of the same samples to check for the effects of the single-cell 
preparation. To this end, the single-cell RNAseq data was compared with the bulk polyA-
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RNAseq libraries prepared from isolated mouse glomeruli before and after dissociation to 
single cells (named bulk1 and bulk2, respectively). (Figure 7.31-A) Despite of an expected 
correlation between the bulk mRNAseq with the single cell RNAseq datasets, the abundance 
of cell types was affected by the single cell dissociation. (Figure 7.31-B) The larger proportion 
of podocytes versus the endothelial cells is therefore due to the possible lysis of endothelial 
cell population through the tissue dissociation step.  
 
Figure 7.31: Comparison of single cell RNAseq data with bulk mRNAseq.  
A- Pearson correlations test between Drop-seq single-cell RNAseq and bulk mRNAseq samples. 
Coverage for all datasets is the same. “bulk1” represents the RNAseq data from lysed glomeruli 
(before tissue dissociation to singlet cells) and “bulk2” represents the RNAseq data from lysed single 
cells of the glomeruli (after tissue dissociation to singlet cells by enzymatic digestion). High 
correlation coefficients are seen for both bulk samples, however, bulk2 correlation with the single-
cell data is better as expected. B- Pairwise comparison of bulk1 and 2 samples for the 50 most 
variable genes per cell type identified in the single-cell RNAseq data. As shown, podocytes are 
overrepresented in the "bulk2" sample compared with “bulk1” which explains the bias imposed by 
the enzymatic digestion and single cell preparation workflow. In the same context, endothelial and 
mesangial cells exhibit a higher dispersion in an opposite direction and the tubular cells are 
seemingly not affected by the single cell preparation. Image adapted from (Karaiskos et al., 2018) 
  
 Single-cell transcriptomics reveal novel molecular markers specific to 
glomerular cell types. 
Bulk mRNAseq studies often fail to identify very low and yet unique transcripts whose 
presence can only be detected in single cell RNAseq experiments. Since this study was the first 
single-cell transcriptomic analysis of the isolated mouse glomeruli, the next focus was directed 
to the identification of novel markers for the main three glomerular cell types. At first, a list 
of known marker genes was compiled by identification of highly variable genes between 
podocytes, endothelial cells and mesangial cells. A thorough literature review was conducted 
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to complete the list and then, novel markers were identified and re-approved on the protein 
level using immunostaining images of the Human Protein Atlas (Figure 7.32).  
 
Figure 7.32: Identification of novel markers for three main glomerular cell types.  
Violin plots show the distribution as well as the relative expression of highly variable genes in 
endothelial cells, mesangial cells and podocytes. The first and second columns denote established 
and novel markers, respectively. The Right panel represents the immunohistochemistry images of 
such markers from Human Protein Atlas (HPA) validating the novel marker prediction from our 
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single-cell RNAseq dataset. Image areas are shown in 500x500 pixels =200 µm2. Image adapted from 
(Karaiskos et al., 2018) 
 
 Sub-clustering reveals the presence of endothelial subpopulations. 
An advantage of single cell RNA sequencing is the identification of cell heterogeneity in each 
cell population. Thus, sub-clustering was performed for podocytes and endothelial cells as the 
two larger cell population within the glomerulus. Endothelial cells showed 5 distinct sub-
clusters. (Figure 7.34-A, B) However, the sub-cluster 4 showed high expression values for 
podocyte-specific marker genes. Therefore, it was identified as a residual cell doublet cluster 
and it was eliminated from further analysis. The remained four sub-clusters exhibited an equal 
distribution among all four replicates. (Figure 7.34-C, D) 
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Figure 7.33: Subclustering of glomerular endothelium.  
A- tSNE representation of endothelial cell subclusters. Five subclusters are identified. Cluster 4 
exhibits expression of podocyte-specific genes such as Nphs2 and Cdkn1c and represents residual cell 
doublets. Cluster 4 is regressed out from further analysis. B- Violin plots show distribution and 
relative expression of highly variable genes within each subcluster. C- tSNE plots show all four 
biological replicates contribute to all subclusters. D- Waffle plots show distribution of all four 
replicates in the endothelial cell subclusters. Each square depicts 1% of the total cell number per 
subcluster. Image adapted from (Karaiskos et al., 2018) 
 
 Functional annotation of the endothelial cell subclusters using pathway and gene set 
overdispersion analysis revealed four distinct cellular processes (cell adhesion, cell 
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maturation, stress response, and cell proliferation) which might imply different states of 
endothelial cells from homeostasis to activation. (Figure 7.34-A) 
Interestingly, the Human Protein Atlas images of the kidney sections for some of the 
subcluster determining genes namely S100a4, Thbd, Hspa1b, and Fbln2 showed a 
heterogenous staining pattern on the protein level. (Figure 7.34-B) However, it is not known 
if this heterogeneity stems from the individual cell localization within a healthy capillary tuft 
or it reflects localization in other parts of the kidney. Thus, it is the subject for further 
investigation.  
 
Figure 7.34: Endothelial subclusters are responsible for various cellular functions.  
A- The heatmap depicts four distinct endothelial functions relevant to endothelial subclusters as 
identified by the pathway and overdispersion analysis. (the colored bar on the top represents 
endothelium subclusters (0: red; 1: green; 2: blue; 3: purple) B- The immunohistochemistry images of 
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selected subcluster markers (S100a4, Thbd, Hspa1b, and Fbln2) from Human Protein Atlas (HPA) 
validates endothelial cell heterogeneity in human glomeruli. Endothelial cells are identified by 
intracapillary nuclei. Red arrows and the corresponding insets depict strong S100a4 expression and a 
positive expression for Thbd, Hspa1 and Fbln2 proteins. Green arrows, on the other hand, depict 
weak S100a4 expression or no expression for Thbd, Hspa1 and Fbln2 proteins. Image areas are 
shown in 50x50 pixels =20 µm2. Image adapted from (Karaiskos et al., 2018) 
 
 Sub-clustering reveals a limited heterogeneity of podocytes. 
Although sub-clustering in podocytes was based on a more subtle gene expression difference, 
it identified seven categories. (Figure 7.35-A, B) However, a marked stress response signature 
was found in cluster 4 which can be explained by the tissue dissociation procedure and its 
following gene expression modification. In line with this, an increased expression of stress 
response genes in bulk 2 dataset was detected compared to the bulk 1. Therefore, all the 
stress response genes were excluded from further analysis and re-clustering was performed 
which identified six subclusters. (data not shown here) The remained six subclusters exhibited 
an equal distribution among all four replicates. (Figure 7.35-C, D) From all six categories, 
subclusters 3 to 5 were identified robustly and marker gene analysis revealed some genes and 
transcripts from mouse-specific microRNAs and noncoding RNAs. Meanwhile, the other three 
clusters did not exhibit specific marker genes and/or transcripts. As the number of coding 
transcripts were not enough to draw a meaningful conclusion by functional analysis, pathway 
and gene set overdispersion analysis did not show conclusive results.  
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Figure 7.35: Subclustering of glomerular podocytes.  
A- tSNE representation of podocyte subclusters. Six subclusters are identified after exclusion of 
the stress response genes. B- Violin plots show distribution and relative expression of highly 
variable genes within each subcluster. C- tSNE plots show all four biological replicates 
contribute to all subclusters. Cells are color-coded per replicate. D- Waffle plots show 
distribution of all four replicates in the podocyte subclusters. Each square depicts 1% of the 
total cell number per subcluster. Image adapted from (Karaiskos et al., 2018) 
 
However, immunofluorescence staining of Lars2 and Cald1 on the isolated glomeruli from 
Nphs2Cre x mTmG mice showed heterogenous colocalization of these sub-cluster markers in 
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podocytes. (Figure 7.36, Figure 7.37) Both Lars2 and Cald1 have established role in podocytes. 
Lars2 is a mitochondrial Leucyl tRNA synthetase which is mutated in hereditary FSGS. (Cheong 
et al., 1999; Jansen et al., 1997) 
 
Figure 7.36: Laser scanning confocal microscopy of Lars2 staining in double-fluorescent reporter 
mice.  
Matrigel-embedded glomeruli isolated from perfused kidneys of transgenic Nphs2CrexmTmG CD1 
male mice are stained with Lars2 antibody or IgG control. Podocytes express membranous green 
fluorescent protein (GFP) in the presence of Cre while non-podocyte cells express membranous 
Tomato (Red). Yellow squares depict magnified areas of the podocytes. Yellow arrowheads point to 
the differential Lars2 signal in two different podocytes whereas IgG staining is expectedly negative. 
Scale bar: 10 µm. Magnified areas: 22x22 µm2. Image adapted from (Karaiskos et al., 2018) 
Cald1 or Caldesmon 1 interacts with actin, myosin and calmodulin and it is crucial for non-
muscle cell contraction. Cald1 has been shown to be involved in the development of diabetic 
nephropathy. (Jiang et al., 2016; Śnit et al., 2017; Wang et al., 2016) Taken together, podocyte 
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heterogeneity is highly probable in healthy mouse glomeruli. However, more data from other 
animal models as well as human samples is needed to validate this heterogeneity in kidneys.  
 
Figure 7.37: Laser scanning confocal microscopy of Cald1 staining in double-fluorescent reporter 
mice.  
Matrigel-embedded glomeruli isolated from perfused kidneys of transgenic Nphs2CrexmTmG CD1 
male mice are stained with Cald1 antibody or IgG control. Podocytes express membranous green 
fluorescent protein (GFP) in the presence of Cre while non-podocyte cells express membranous 
Tomato (Red). Yellow squares depict magnified areas of the podocytes. Yellow arrowheads point to 
the differential Cald1 signal in two different podocytes whereas IgG staining is expectedly negative. 
Scale bar: 10 µm. Magnified areas: 22x22 µm2. Image adapted from (Karaiskos et al., 2018)  
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8 Discussion 
8.1 Wt1 reprograms podocytes in the face of damage.  
The identification of Wilm’s tumor 1 (WT1) gene roots back to 1990 when it was found as a 
genetic predisposition resulting in Wilm’s tumor. (Call et al., 1990; Gessler et al., 1990) Wt1 is 
a highly diverse protein and is encoded by ten exons. Thus far, 36 isoforms have been reported 
in mammals generated by alternative transcription and translation start sites, alternative 
splice sites and RNA editing strategies. (Hastie, 2017)  
In the adult kidney, Wt1 expression is restricted to podocytes nuclei and there is a balance 
among its isoforms including the mostly studied ones i.e. +KTS and -KTS isoforms. (Ullmark et 
al., 2018) Noticeably, kidney disease phenotypes attributed to mutations of Wt1 can directly 
reflect the specific role of this protein during development and/or after differentiation. Often, 
developmental syndromes and malignancies which arise from mutations of Wt1 compromise 
the KTS isoforms and/or zinc fingers. On the other hand, mutations which result in 
glomerulosclerosis often happen in less important domains but show the key role of Wt1 in 
the maintenance of glomerular structure and function. 
In this thesis, a mouse model of glomerulosclerosis is used in which exon 1 is deleted in one 
of the Wt1 alleles. Heterozygous deletion of Wt1 does not compromise the kidney 
development as evaluated by the morphological as well as functional analysis of the mice at 
the postnatal day 6. The shape and weight of the Wt1 het del mice show no difference with that 
of the control mice. Moreover, the kidneys function normally and there is no trace of 
proteinuria in Wt1 het del mice. 4-week old mice, however, show significant proteinuria and 
slight GBM thickening and effacement. This is the early phase of FSGS when sclerosis is not 
yet evident (Early FSGS). 12-week old mice, moreover, manifest an explicit sclerosis besides 
the proteinuria (Late FSGS). This data confirms the previous findings by Menke and his 
colleagues in 2003. They found that the early indications of nephropathy in Wt1 het del mice is 
proteinuria and glumerosclerosis occurs relatively late. (Menke et al., 2003)  
As the Wt1 het del mice show a gradual development of FSGS, it serves as a reliable model to 
perform a time-course analysis of Wt1-dependent gene regulation in the course of disease.  
In these mice, Wt1 commands podocytes to adopt a differential transcriptomic signature 
during FSGS progression. Differential binding analysis of the Wt1 ChIPseq peaks across the 
genome is suggestive of a general reprogramming phenomenon directed by Wt1. There is 
solid evidence in the literature on the modulation of epigenetic landscape by Wt1 in different 
cell types during disease progression. One of which is the study performed by Rampal and his 
colleagues where they show differential expression of Wt1 in acute myeloid leukemia (AML) 
leading to changes in 5-hydroxymethylcytosine (5hmC) levels and the subsequent gene 
expression modification. (Rampal et al., 2014)  
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Another interesting aspect of Wt1 activity is a phenomenon termed as “chromatin flipflop”. 
This term was first suggested by Essafi and his colleagues when they refer to the reciprocal 
function of Wt1 in the heart versus kidneys through regulation of Wnt4. Wt1 is responsible 
for mesenchymal to epithelial transition (MET) in the kidneys whereas it does the reverse job 
in the epicardium (EMT). In both tissues, Wt1 induces global changes in chromatin accessibility 
by switching the CTCF boundaries. (Essafi et al., 2011) 
Taken together, these pieces of evidence substantiate our finding on the ability of Wt1 to 
modify the chromatin landscape and reprogram podocytes to adopt an alternative 
transcriptomic signature during the progression of glomerulosclerosis. However, the 
mechanism by which Wt1 induces changes in chromatin accessibility and gene expression 
during FSGS needs to be further investigated.  
8.2 Collagen Biology is one of the main functional targets of Wt1 
during the development of FSGS.  
In this thesis, an elaborate expression profile of all collagen types is provided for the first time 
in the course of podocyte disease. Thus far, majority of the existing studies have focused on 
array data from patient and or mice samples. (Hodgin et al., 2010; Ju et al., 2009) Here, the 
differential expression analysis of the RNAseq data shows a significant down regulation of Col 
IV a3,4 and 5 transcripts in late FSGS whereas Col IV a1 and 2 transcripts have upregulated 
both in early and late FSGS. Moreover, STED images of the GBM from Wt1 het del mice highlights 
the disrupted collagen IV synthesis by appearance of collagen humps along the basement 
membrane. 
Collagens, especially type IV, are the indispensable units for the strength and stability of the 
GBM. (Chew and Lennon, 2018; Pöschl et al., 2004) Col IV a1,a1,a2 is the predominant form 
in developing glomeruli whereas Col IV a3,a4,a5 is found in mature GBM . (Abrahamson et al., 
2009) Evidence from the literature suggests that perturbations in the Col IV isoforms is linked 
to different kidney diseases in patients as well as mice. Handfuls of the existing publications 
have focused on Col IV mutations in Alprot syndrome where mutations in Col4A3, Col4A4, and 
Col4A5 lead to a deficiency in shifting from ColIVa1,a1,a2 to ColIVa3,a4,a5. (Lennon et al., 
2014; Noone and Licht, 2013) Gast and his colleagues suggest that Col IV mutations are one 
of the underlying causes of hereditary FSGS. (Gast et al., 2016) In a pilot study of a family with 
a history of glomerular disease, Lennon and her colleagues have shown concomitant Col IV a5 
and MYO1E mutations exacerbates the kidney damage. (Lennon et al., 2015) In addition, Col 
IVa3 and 4 transcripts are reduced in a mouse model of nephrotic syndrome as a result of 
conditional Lmx1b deletion. (Morello et al., 2001) In patients with minimal change disease 
(MCD), dissected glomeruli show increased Col IV a1,a1,a2 expression. (Hodgin et al., 2010) 
These studies support the observations made in Wt1 het del mice. Conclusively, alterations in 
Col IV subtypes is one of the key events in during the podocyte injury.  
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In this thesis, differential expression of Col IV is shown on the protein level. However, the 
antibody which was used in staining does not differentiate between the Col IV isoforms. 
Therefore, it might worth investigating how the dynamics of Col IV isoforms fluctuate in the 
course of disease using targeted mass spectrophotometry of whole glomeruli lysates.  
8.3 Ephrin Signaling pathway is a novel target of Wt1 during 
podocyte damage.  
In this thesis, integrated ChIPseq and RNAseq analysis of Wt1 het del mice are suggestive of a 
marked repression for the “Ephrin Signaling” pathway both on the gene and the transcript 
level. Moreover, several players of the Eph/Ephrin signaling pathway have shown a significant 
differential expression including EphrinB1 and EphB1 which have been downregulated both in 
early and late FSGS.  
In podocytes, EphrinB1 and its receptor EphB1 have the highest expression compared to the 
other Ephrins and Ephs. (Karaiskos et al., 2018) Therefore, it is valid to speculate that majority 
of the “Ephrin Signaling” commands are initiated by these two proteins. Thus, further 
experiments were focused on EphrinB1 and EphB1. Targeted mass spectrophotometry shows 
a marked reduction of EphrinB1 in late FSGS. Furthermore, co-staining of the kidneys with 
Ephb1 and EphrinB1 in Wt1 het del mice demonstrates an explicit reduction of their signal which 
is more pronounced at sclerotic stage (12-week het del mice) compared to healthy animals. 
Remarkably, the reduction in EphrinB1 signal intensity is highly correlated with the extent to 
which sclerosis is progressed. These findings are in line with the existing literature as in human 
patients with active nephrotic syndrome, a clear reduction in EphrinB1 signal is observed in 
immunofluorescent images. Moreover, conditional deletion of EphrinB1 in podocytes leads to 
the development of proteinuria and foot processes effacement in mice. (Fukusumi et al., 
2018) EphrinB1 localizes at the slit diaphragm and contributes to the maintenance of the 
barrier function. (Hashimoto et al., 2007) Fukusumi and his colleagues maintain that when the 
podocytes are offended by a primary cause, EphrinB1 is phosphorylated and promotes cell 
motility via a JNK-dependent mechanism. They claim this chain of events mechanistically 
explains the process of podocyte detachment during injury (Fukusumi et al., 2018) 
The initial cellular cascades triggered by Eph/Ephrin signaling converge on cytoskeletal targets 
such as integrins and actin cytoskeleton modulators mainly Rho GTPases. (Coulthard et al., 
2012; Lisabeth et al., 2013) Both cytoskeletal targets dictate how podocytes tolerate intra 
and/or extracellular offenses by modulating the general shape of foot processes as well as 
attachment/detachment balance to the GBM. Therefore, an Eph/Ephrin-promoted actin 
(de)polymerization disbalance might be another possible explanation for podocyte 
detachment and loss during FSGS progression. However, further investigation needs to be 
conducted as to when and how the Eph/Ephrin signaling joins the stage in the course of 
glomerulosclerosis. 
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8.4 Tead1 exerts the Hippo pathway-mediated gene regulation in 
podocytes. 
The tissue distribution of TEAD TFs varies from one organ to another. This thesis has addressed 
the podocyte specific expression of TEADs for the first time. Tead1, 4 and 3 are expressed in 
the kidneys and Tead1 is expressed significantly higher in podocytes. This novel piece of 
information is complementary to the existing knowledge on the expression dynamics of the 
TEAD TFs in different cell types in the body. At the 2-cell stage, Tead2 is predominant among 
other TEADs. (Kaneko et al., 1997) During development, Tead2 is specifically expressed in 
some embryonic tissues such as testis, forelimb and hindlimb buds, cerebellum and tail bud. 
(Yasunami et al., 1995) In contrast, Tead1, 3, and 4 are the widespread forms in tissues such 
as heart, pancreas, lung and skeletal muscle during adult life. (Azakie et al., 2005; Stewart et 
al., 1996; Yasunami et al., 1996) Since Tead1 is the predominant form of TEAD TFs in 
podocytes, it serves as the main downstream effector of the Hippo pathway.  
Immunofluorescent staining of the Tead1 shows that it is mainly localized in the nucleus of 
normal healthy podocytes. Regulation of TEADs is mediated through different mechanisms 
and subcellular localization is one of the mechanisms by which TEADs molecular function is 
controlled. Hyperosmotic pressure and cell detachment lead to cytoplasmic localization of 
TEADs which is mediated via p38 mitogen-activated protein kinase (p38 MAPK) activity. (Lin 
et al., 2017) Cellular stress induces modifications in the subcellular localization of TEADs 
through P38 MAPK. This mentioned, it might be highly interesting to investigate the 
fluctuations of Tead1 subcellular localization during podocyte injury.  
The nuclear localization of Tead1 in healthy podocytes suggests active gene regulation via 
Tead1. De novo motif enrichment analysis of the Tead1ChIPseq data from isolated mouse 
glomeruli identifies the consensus binding region of 5′-CATTCCA/T-3′ for Tead1. In TEAD(s), 
TEA is the DNA binding domain (DBD) which binds to the same consensus sequence known as 
MCAT element. (Farrance et al., 1992) Moreover, Tead1 is functionally involved in pivotal 
cellular processes in podocyte biology. Functions include but not limited to cellular adhesion 
and actin-based cellular organization. Likewise, Tead1 functions in non-podocyte cells have 
been addressed in a handful of other studies where the actin cytoskeleton organization and 
focal adhesion have recurrently appeared. (Liu et al., 2017; Stein et al., 2015)  
Majority of Tead-mediated functions are believed to be mediated via enhancers. (Davidson et 
al., 1988; Stein et al., 2015) In line with this, analysis of Tead1 binding across the genomic 
features shows that Tead1 predominantly binds to intergenic and intronic sites in podocytes. 
Altogether, Tead1 orchestrates its gene-regulatory functions by chiefly binding to putative 
enhancers in wildtype mouse glomeruli. The main cellular processes that are governed by 
Tead1 in podocytes involve cell adhesion and actin cytoskeleton dynamics.  
One of the key findings of gene regulation in podocytes is the cooperation possibility between 
Tead1 and Wt1 on gene regulatory regions. (Kann et al., 2015) Strikingly, the co-binding 
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analysis of the Tead1 and Wt1 on gene regulatory elements revealed a functional alliance 
between these transcription factors for regulation of key podocyte functions such as actin 
cytoskeleton assembly and cell adhesion. More than 70% of the total co-binding occurs at 
distant regulatory regions which further substantiates the importance of enhancer-dependent 
functions in podocyte homeostasis. Of note, TEA domains require cooperative binding to 
regulatory elements, and they are believed to bind cooperatively to tandem repeats. 
(Davidson et al., 1988) This property perfectly matches with what is found in the co-binding 
analysis. Majority of Tead1 target genes are likely to be co-dependent on Tead1 as well as Wt1 
binding. Further investigation is needed as to which DNA sequences call for Tead1 and Wt1 
co-binding and which of such sequences code for key podocyte genes.  
8.5 The puzzle of gene regulation in podocytes 
A very interesting breakthrough in the gene regulation arena is the higher resolution datasets 
gained from single-cell omics studies such as single cell RNA sequencing, single cell 
epigenomics, etc. Such studies have facilitated understanding of the crosstalk between 
different kidney cell types and the gene regulation by transcription factors and other 
epigenetic regulators. (Lambert et al., 2018; Park et al., 2019) In this thesis, a single-cell 
RNAseq atlas of the mouse glomeruli is introduced to the kidney research community. Besides, 
a free online webtool is provided which can be queried based on a single gene or a set of gene 
names. (https://shiny.mdc-berlin.de/mgsca/) For the first time, an exhaustive resource of 
gene expression for individual glomerular cell types is published. Off note, earlier attempts in 
this direction consisted of very few cells and their focus was directed to one certain cell type. 
For example, single cell RNA sequencing of 20 mouse podocytes showed that majority of 
essential podocyte genes are linked to cytoskeleton. (Lu et al., 2017) Our dataset, however, is 
gained from an unbiased highly parallel single-cell profiling of nearly 13,000 cells and thus the 
readout is more solid comparing to the previous studies. 
One of the key findings in this thesis is the identification of several novel markers for 
podocytes, endothelial cells and mesangial cell which were not found to date. One advantage 
of single-cell RNA sequencing technology is its ability to identify novel markers. During “bulk 
RNA sequencing”, the lower abundance transcripts are often masked by the higher abundance 
transcripts and there is always a fair chance that they are not detected although they might 
bear very important biological impacts. (McCarthy et al., 2017) This limitation is surpassed in 
our dataset and the identified novel markers are validated using the immunohistochemistry 
images obtained from the Human Protein Atlas.  
Another key merit of the single cell RNA sequencing technology is its ability to decipher cell-
to-cell variability within a sample. In this regard, Der and colleagues have addressed cell 
heterogeneity of the kidney and skin specimens of patients suffering from lupus nephritis to 
identify novel diagnostic markers. This group claims that the assessment of kidney injury in 
lupus nephritis patient can be facilitated by the utilization of accessible skin tissue. (Der et al., 
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2017) Here, our dataset is examined for potential cell heterogeneity among podocytes and 
endothelial cells. Individual cell subpopulations are identified in podocytes and endothelial 
cell clusters. The endothelial cell clusters reflect different stages of endothelial cell activation 
and proliferation. Furthermore, the podocyte subpopulations are validated by 
immunofluorescent staining of the relevant subtype markers. Perhaps, cellular diversity is one 
of the key possibilities as to why certain populations of podocytes and endothelial cells are 
more susceptible to damage in response to external and internal stimuli. However, it is not 
valid to extrapolate the findings of podocytes and endothelial cell subpopulations to the all 
the mouse strains as well as human. The former, our dataset is comprised of a certain mouse 
strain, sex and age. The latter, although a great proportion of the identified cells have a 
glomerular origin, there is a chance that the identified endothelial cells have an 
extraglomerular source. Despite all the discussed caveats, the single-cell transcriptome atlas 
provided in this thesis can serve as a valuable resource for further studies in the same 
direction.  
8.6 Concluding remarks 
Efficacious management of chronic kidney disease requires informed classification of the 
underlying etiology. Be it diabetes, virus-associated, malignancies or idiopathic, podocyte 
damage is the first cause of proteinuria and the drop in GFR.  
In the context of hereditary FSGS, handfuls of genes have been reported as causal which 
contribute to the pathogenesis of podocyte injury. Master podocyte transcription factors as 
well as chromatin modifiers constitute a large proportion of the causal mutations for podocyte 
damage. Deciphering how the transcriptional regulation circuit works in podocytes paves the 
ground for introducing novel therapeutic routs during the initial phases of the podocyte 
damage.  
In this thesis, we have focused on different and yet interesting aspects of transcriptional 
regulation in podocytes. The complementary characteristic of our results points out to certain 
features of gene regulation in healthy as well as injured podocytes.  
One of the key strengths of this thesis is that the relevance of disease progression to the 
observed cellular phenotypes is discussed for the first time. The dependence of EphrinB1 
reduction in the course of podocyte damage is a clear example of how time-course 
investigation into disease processes could offer new avenues in the management of disease 
phenotypes. Additionally, we have shown several functional perturbations in podocytes 
during the progression of FSGS one of which is the “Collagen Biology” which is extensively 
discussed. However, only one genetically modified mouse model has been employed in this 
thesis as the model for hereditary FSGS. Expectedly, other FSGS mouse models elicit several 
mutual cellular functions as well as some novel pathways contributing in different stages of 
the disease. It is intriguing to utilize the data obtained from different FSGS models as an input 
for a network-based analysis of key mechanisms underlying podocyte damage.  
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Another key finding in this thesis is the functional analysis of co-binding for two podocyte-
specific master TFs, Wt1 and Tead1. A very tantalizing next step in this direction would be to 
investigate the co-binding in podocyte disease setting.  
Last but not the least, we have employed the power of single-cell transcriptome profiling to 
introduce novel markers for podocytes, endothelial cells as well as mesangial cells. What is 
more, the possibility of cell heterogeneity is investigated for endothelial cells and podocytes. 
Future studies are needed to unravel whether our claimed subcellular populations are justified 
in other mouse strains as well as humans. 
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